Apr 24, 2019 04:10 pm Views: 4210\ni;a;aj iajrEm ú,dis;d udOùg tmd¨\n*eIka .ek fudlo ys;kafka@\n*eIka lsh,d uu ys;kafka uQÙ tlla' wmg ta fj,dfõ§ oefkk úÈh ;uhs *eIka lshkafka' wms iyNd.S jk wjia:dj fyda wmg oefkk úÈh wkqj jf.au wms w¢k m<¢k úÈfhka wfma fm!reI;ajh ta jf.au wfma is;=ï me;=ï ;SrKh fjkjd'\nTõ yßhgu yß' fmrÈ. fyda ngysr jqj;a we;a; we;s ieáfhka ksrEmKh lsÍu yd udkj wNHka;rh ksrEmKh lsÍula ;uhs l,dj lshkafka' ta l,djg *eIka we;=<;a fjkjd' iuyr wh f.dvla foaj,a we÷u ;=<ska fmkajkjd' wdrlaIdj uQ,sl lr.kakjd' uu;a uf.a m%;sm;a;shla úÈhg i;a;aj iajrEm ;sfhk fyda tjeks ueàßh,a j,ska lrk *eIka w¢kafka keye' ta yeu foau ksid n,oa§ *eIka lshkafka l,djla lshk tl ksjerÈhs'\nldka;djla *eIka lrkak ´k fldfyduo@\nldka;djla ú;rla fkfjhs ´ku flfkla *eIka lrkak ´k ;ukag .e<fmk úÈhg' ;uka iyNd.sjk wjia:dj wkqj jf.au ;ukag .e<fmk úÈhg f;dar.kak ´k'\nwkqlrKhla fkfjhs flfkla Èyd n,,d w¢kak mq¿jka' ta foa oelalu ;uhs *eIka ìysfjkafka' uu fm!oa.,slj uq,skau wkqlrKh lf<a uf.a fouõmshka' uf.a wïud wmamÉÑ w¢k úÈhg ;uhs uu w¢kak leu;s' Bg miafia ;uka leu;s pß; wkqj w¢kak ysf;kjd' ta foa fjkafk;a bfíu' fmdä <uhl=f.ka yß .kak fohla ;sfhkjkï uu .kakjd'\nmqreoaola úÈhg ief,daka hkjo@\nuu f.dvla fj,djg ief,daka hkafka fyhd¾ iaghs,a tlla od.kak ;uhs'\nleu;su hair style tl lsõfjd;a@\nuu f.dvla leu;s ¨ia fyhd¾ tlg' ug ,iaik fmkqula taflka ,efnkjd lsh,d uu ys;kjd'\niudc uÜgu wkqj uqyqfKa yevh wkqj ta foa tl tlaflkdg fjkia fjkjd' wms ljodj;a ys;,d kEfka vhkd l=ußhg fldKavh jejqfjd;a fyd|hs lsh,d' ta jf.a wmg ;j flkl=f. foa yßhgu lshkak neye'\nwe;a;gu uu mqreoaola úÈhg Trf,daiq me<ÿfj keye' ug ñ,dka biafi,a,du je,kaghska tlg ÿkak Trf,daiqj ;uhs Ôúf;a m<fjks j;djg nekafoa' uu oeka mdúÉÑ lrkafka;a ta Trf,daiqj'\nuu ys;akafka f*daka tlla mdúÉÑ lrkafka wjYH;djka j,g'\nhand bag tl yeu .ukl§u jeo.;a fkao@\nTõ' uu nE.a udrelrkjd wvqhs' úfYaI wjia:djkaj,§ we÷ñka we÷ug fmdä m¾ia tlla mdúÉÑ lrkjd'\nuu fIdmska lrkjd' uu we|,d n,,d ;uhs .kafka' uu iy uf.a mjqf,a wh f.dvla YÍr fi!LH .ek ys;kjd' ta ksid ug weÿï fydhd.kak wudre keye'\nuu f.dvla leu;s *a,eÜ fifrmamq j,g ;uhs' idß tllg jf.akï yhs yS,a tlla odkjd'\nidudkH .ukla hoaÈ wÈkak leu;su weÿula ;sfhkjdo@\nuu leu;s fvksï tlla iy à I¾Ü tlla fyda .jqula'\nwedding tllg hoa§ w¢kak leu;s fudk weÿulao@\nuu leu;s idß tlla w¢kak' uf.a yevhg .e<fmkafka idßh lsh,d uu ys;kjd'\ncqj,ß kï mdúÉÑ lrkafka we÷ñka we÷ug' uu .,jkafka ke;=ju m<¢kafka uÛq,a uqoao ú;rhs'\n*eIka lroaÈ jim hkaku ´ko@\n*eIka tllg fkfjhs YÍr fi!LH mj;aj .kak ðï tlg hkak ´k' jHdhdu lrkak ´k' ke;a;ï fhda. lrkak mq¿jka' fhda. iy jHdhdu rgdjla ´ku whl=g ;sfhkak ´k'\nuu ys;kjd uf.a YÍrhg .e<fmkafka fjdaï l,¾ lsh,d' r;= ;eô<s jf.a mdg;a w¢kjd' Bg wu;rj iqÿ ly uu leu;su j¾Khka' uu leu;s j¾Kj;a weÿï j,g' <ÛÈ b|ka ,hsÜ l,¾ia w¢kak mqreoaola we;sfj,d ;sfhkjd'\n*eIka lroa§ YÍr j¾Kh flfrys ie<ls,su;a fjkak ´ko@\nTõ''' wksjd¾hfhkau ie<ls<su;a fjkak ´k'\nkeye' wudrefj jeá,d kï keye'\nfyhd¾ l,¾ lrkak leu;s keoao@\nuu leu;shs' kuq;a fyhd¾ tlg vefïÊ fjkjd' jD;a;sh;a tlal fyhd¾ l,¾ lsÍfï fkdyelshdjla ;sfhkjd' úúO pß; rÛmdkak jk ksid'\n*eIka lroaÈ n,kafka myiqjo@ ir<luo@\nuu n,kafka myiqj'\ngegQ *eIka j,È w;HjYHo@\n*eIka j,§ w;HjYHu keye' ta;a iuyr flkl=g leu;skï lrkak mq¿jka' tafla je/oaola uu olskafka keye'\nújdyfhka miafia *eIka fjkia fjkjd lsh,d ys;kjdo@\nkeye' újdy jqKd lsh,d ;uka fjkia fjkafka keyefka'


Cigarette Cards and How To Collect Them - I.O. Evans; | Foyles Bookstore\nYou are browsing: All Cigarette Cards and How To Collect Them\nCigarette Cards and How To Collect Them (Paperback)\nArt, Fashion & Photography Antiques & collectables Books, newspapers, magazines, comics, autographs Publisher: Read Books Publication Date: 01/01/2006 ISBN-13: 9781846641107 Details: Type: Paperback Format: Books\nMore books by I.O. Evans


Railway Herald :: Imaging Centre :: 142091 at Pontefract Monkhill\nImages from Pontefract Monkhill\nNorthern Class 142 'Pacer' DMUs Nos. 142091 & 142032 arrive at Pontefract Monkhill as they work the 09:28 Leeds to Knottingley service on 30th November 2019. Following the cancellation of the previous train, a number of people are waiting on the opposite platform for the next service to Leeds, which the two 'Pacers' would form once they reached Knottingley.


Edrych yn ôl ar wythnos yr Archdderwydd | Eisteddfod Genedlaethol\nBu’n wythnos brysur i Myrddin ap Dafydd yn yr Eisteddfod yr wythnos ddiwethaf.\nRoedd yn gyd-awdur un o sioeau mawr yr wythnos, yn un o feirniaid cystadleuaeth y Gadair, yn gyfrannwr mewn nifer fawr o sesiynau ac yn stondinwr. Byddai hyn wedi bod yn ddigon i drechu’r rhan fwyaf o Eisteddfodwyr.\nOnd, ar ben hyn oll, hon oedd wythnos gyntaf Myrddin fel Archdderwydd, gyda’i gyfnod o dair blynedd yn arwain yr Orsedd yn cychwyn yn ei dref enedigol, Llanrwst.\nOs oes un gair wedi’i ddefnyddio i ddisgrifio seremonïau cyntaf Myrddin wrth y llyw, ‘urddasol’ yw hwnnw, ond rhyw urddas agos-atoch a chyfeillgar oedd ganddo wrth groesawu tri enillydd teilwng iawn i lwyfan y Pafiliwn. Roedd ei edmygedd o’r tri yn amlwg, a’i groeso cynnes a’i gefnogaeth wrth iddyn nhw ddringo’r grisiau i’r llwyfan i’w weld yn glir.\nDyma Archdderwydd sy’n amlwg am i Gymru gyfan ymlawenhau yn llwyddiant ein beirdd a’n llenorion, ac sy’n poeni dim iot ei fod yn amlwg i bawb ei fod yn gefnogwr brwd o waith yr enillwyr. Dyma Archdderwydd sy’n edrych i’r dyfodol, ond sydd â pharch at draddodiad a chanrifoedd o hanes ein gwlad a Gorsedd y Beirdd, ond sy’n gweld rôl fodern a phwysig i’r Orsedd mewn cyfnod tymhestlog yn hanes Cymru.\nMae Myrddin am i’r Orsedd estyn allan i’r byd; nid sefydliad mewnblyg yw’r Orsedd ond yn hytrach, corff cynhwysol a chyfartal o ran ei nod. Meddai, “Does dim rhaid bod o dras Gymreig na Cheltaidd i gael eich derbyn i Orsedd y Beirdd – dim ond eich bod yn medru’ Gymraeg ac wedi wneud cyfraniad i'r wlad a'i diwylliant.\n“Derbyniwyd Berno o'r Iseldiroedd, Phillip o Barbados, Daniela o'r Almaen a Bev o Brixton sy'n ferch i un o deuluoedd y 'Windrush' i'r Orsedd yn Llanrwst. Rydan ni'n symud rwan at berthynas newydd rhwng Cymru a'r byd, nid Cymru o fewn cyd-destun hanesyddol Brydeinig.”\nOnd perthynas newydd yw hon, heb golli golwg ar draddodiad a hanes sy’n dyddio’n ôl dros ddwy ganrif, ac mae Myrddin yn falch iawn o gael arwain sefydliad sydd ag arwyddocâd mor bwysig iddo am gynifer o flynyddoedd. Ond mae’n rhaid wrth ddatblygu ac esblygu, a chyhoeddwyd yr wythnos ddiwethaf mai ‘Gorsedd Cymru’ fydd yr enw cyhoeddus ar Yr Orsedd o hyn ymlaen. Ydi hyn yn troi cefn ar weledigaeth Iolo Morganwg, yn dangos diffyg parch i ddwy ganrif o hanes?\n“Ddim o gwbl,” yn ôl Myrddin. “‘Does dim ymgais i ddileu hanes na dad-wneud gwaith Iolo. Mae’r Cyfansoddiad yn dal i gyfeirio at Orsedd Beirdd Ynys Prydain, a does dim ymgais wedi’i wneud i ddileu hynny. Mae’r byd wedi newid dros y 227 o flynyddoedd diwethaf. Nid ein Gorsedd ni yw’r unig un erbyn heddiw, ac mae Gorsedd Cymru’n adlewyrchu hynny.\n“Mae ambell un wedi bod yn gweld bai ein bod ni am arddel yr enw Gorsedd Cymru ar gyfryngau cymdeithasol. Mae ambell un yn teimlo ein bod yn cefnu ar draddodiad ac yn naïf yn ein gweledigaeth, heb ddeall gwir ystyr ‘Ynys Prydain’ yn enw’r Orsedd.\n“Nid troi cefn ar draddodiad sydd yma, ond yn hytrach, dewis defnyddio enw sy’n addas ar gyfer Cymru wrth i ni agosáu at ail chwarter yr unfed ganrif ar hugain. Ac mae’r mwyafrif llethol yn gweld ac yn deall hyn, gyda’r newid wedi’i basio gan Fwrdd yr Orsedd, aelodaeth yr Orsedd a Llys yr Eisteddfod dros y misoedd diwethaf.\n“Mae'i galw'n Orsedd ‘Beirdd’ yn gamarweiniol hefyd – mae pob celfyddyd a gwyddor, pob camp a chrefft a gyflawnwyd i hybu’r Gymraeg a Chymreictod yn cael eu hanrhydeddu gennym ni, ac mae hyn yn rywbeth i’w ddathlu a’i groesawu. Dyma Gymru heddiw. Dyma ddatblygiad gweledigaeth Iolo. Dyma ein Gorsedd ni’r Cymry, ar ein mwyaf cynhwysol, croesawgar a chan edrych allan ar draws y byd i ddathlu llwyddiannau ein cenedl fechan.\n“Radicaliaeth heddiw, does bosib, ydi hawlio'n lle fel gwlad annibynnol y tu allan i wladwriaeth Prydain, fel cenedl fodern Ewropeaidd sy'n rhan o'r byd ehangach. Mi fyddai Iolo o blaid hynny.”\nRoedd yn amlwg fod torf fawr y Cadeirio wedi deall arwyddocâd cyfoes y newid enw ar amrantiad. “Roedd y gymeradwyaeth yn fyddarol ac ar yr eiliad hwn, mae arwyddocâd cyfoes symud o feddylfryd Prydeinig i un Cymreig yn bwysig i ddyfodol Cymru a’r Gymraeg. Llundain oedd unig brifddinas y Cymry yng nghyfnod Iolo Morganwg ond bellach Caerdydd ydi prifddinas Cymru. Yn ara’ bach, rydan ni'n dymchwel Prydeindod canolog ac yn gorseddu Cymru ddatganoledig. Y Ddraig Goch yn lle’r Union Jack sydd ar ein cynnyrch. Mae hyn yn gam arall ar y daith honno a dyna pam fod yr enw wedi'i dderbyn mor llawen.”\nAc mae’r parch at Iolo Morganwg yr un mor fyw ag erioed heddiw, gyda Jim Parc Nest yn ennill y Gadair bnawn Gwener am awdl arobryn a oedd yn bortread llachar o Iolo Morganwg, yn clodfori’r ysbryd creadigol a radical a oedd yn rhan o anian Iolo, gyda Myrddin yn un o feirniaid y gystadleuaeth.\n“Ro’n i wedi amau mai gwaith Jim oedd hwn. A phan safodd ar ei draed, aeth y Pafiliwn yn wyllt. Pawb am ddangos eu cefnogaeth, ac eisiau bod yn rhan o’r dathlu. A minnau yno’n cael y fraint o’i groesawu i’r llwyfan. Dyna brofiad bythgofiadwy. Cael croesawu un o fy arwyr i lwyfan y Pafiliwn ac yntau wedi ennill y Gadair am awdl am arwr arall. Ac roedd yr eiliad yna’n wych. Bron i ddwy fil o bobl yn dod ynghyd i ddathlu llwyddiant bardd, gan ymfalchïo yn ein traddodiad, yn genedl hyderus yn mwynhau ein hiaith a’n diwylliant.\n“Ac am braf fyddai hi petai modd i ni fod fel hyn bob dydd. Ond, mae ‘na ryw hen gecru’n perthyn i ni fel cenedl hefyd. Rhyw hen daflu bai a hollti blew, yn aml heb fod yn rhan o’r drafodaeth ehangach. Ac mae hyn yn fy nhristau. Dod ynghyd y dylen ni fod yn ei wneud mewn cyfnod cythryblus fel hyn, nid tynnu’n groes am bethau bach.\nA chyda hyn, mae Myrddin yn troi ei olygon at y dyfodol, ac at brosiect sy’n agos iawn at ei galon, un a fydd yn codi proffil yr Orsedd a Chymru mewn gwledydd eraill dros y misoedd nesaf. Ei gynllun yw ymweld â dwy wlad dramor y flwyddyn a chyflwyno darn o waith celf i gofio am ddigwyddiad ac adeg hanesyddol sy'n uno Cymru a'r wlad honno.\n“Rhywbeth personol ydi hwn. Mae'n codi o hanes yr Orsedd fel y sefydliad cenedlaethol cyntaf i hyrwyddo ac amddiffyn Cymru a'r Gymraeg. Yn draddodiadol, mae'r Orsedd yn cynnwys holl feysydd diwylliannol a gwleidyddol y genedl, gyda'r pwyslais ar frawdgarwch, cydraddoldeb a rhyddid.\n“Bydd fy ymgyrch yn canolbwyntio ar feithrin mwy o gysylltiadau arwyddocaol gyda mwy o wledydd – dathlu dolennau hanesyddol, ond hefyd edrych ymlaen at y dyfodol pan fydd gan Gymru gyswllt agos â gwledydd eraill, nid yn unig o ran diwylliant a thwristiaeth, ond hefyd o ran gwleidyddiaeth a masnach.\n“Bydd ymweliad cyntaf Ymgyrch yr Archdderwydd eleni â Gwlad y Basg yr wythnos nesaf. Ym mhorthladd Saint Jean-de-Luz – yn y rhan o Wlad y Basg sydd dan reolaeth Ffrainc – bydd Myrddin yn cyflwyno celf i Gyngor y Ddinas. Yno yr angorodd llongau Cymreig wrth iddynt geisio – a llwyddo yn y diwedd – i dorri blocâd Franco ar y môr i geisio rhwystro bwyd rhag cyrraedd Bilbao newynog yn 1937.\n“Daeth y capteiniaid Cymreig yn fyd-enwog oherwydd eu dewrder a'u penderfyniad. Merch un o'r capteiniaid llwyddiannus oedd un o'r tramorwyr cyntaf i fod yn llygad-dyst i effeithiau cyflafan Gernika ac i ddatgelu hynny yn y wasg.\n“Ac mae’r ymweliad cyntaf hwn yn gyfle i ni gofio a dathlu ein perthynas â gwledydd eraill, ac yn gyfle eto i atgyfnerthu lle’r Orsedd y tu hwnt i ffiniau gwlad, yn sefydliad sydd â rôl bendant i’w chwarae yn cynrychioli Cymru ar lwyfan rhyngwladol, yn dathlu, yn diolch am gyfraniad ein cyd-wladwyr ac yn edrych i’r dyfodol yn hyderus, yn berthnasol ac yn barod i fynegi barn.”


95' Rio Grande project (feedback please (: ) - Jeep Wrangler Forum\n95' Rio Grande project (feedback please (: )\nOkay. Sooooooooooooo, my 95' Rio Grande is sweet. But, I want to make it better!\n---- Any other suggestions, comments or advice is accepted 02-20-2011, 10:35 AM\n!How many people think a SNORKEL is complete BS?!


Author anyAbdel-Rahman, Dina Abdul-Kabir, Saburah Abella, Benjamin SAdams, Nancy KassamAhmedani, Brian K.Airey, Megan Aitken, Leanne MAlbert, Dustin Albert, Dustin Albrecht, Terrance Alderfer, Melissa AAlexander, KA Alisic, Eva Allison, Mari AAllison, Paul DAlonso-Tapia, Jesús Alpern, E RAlpern, EAnderko, R LAnderson, Karen MAndersson, Marianne Angelucci, Jennifer Aplenc, Richard Applegate, S MArbogast, Kristy BArbogast, Kristy BArbogast, Kristy AArena, K Arendt, Florian Armstrong, Daniel FAronson, Paul LAtabaki, Shireen Ato, Tadayuki Babl, Franz EBach, LBadawy, Mohamed Bae, Hanah Bagden, Loretta Baiocchi, Michael Bair-Merritt, Megan HBaker, Douglas MBaker, S PBaker, Courtney NBaker, Julia MBakes, Katherine MBakker, Anne Balasubramanian, Sriram Banwell, Brenda LBarakat, Lamia Barakat, Lamia PBarber, Beth ABaren, Jill MBarg, F KBarg, Frances KBarnes, Richard Baskett, Jerilyn Bass, S.B. Bass, Sarah Basta, Luke Baxt, Chiara Beacham, BBeauchamp, Miriam HelenBecic, Ensar Beck, Robert Becker, Marla Becker, Julie Beer, Darcy Beidas, Rinad S.Belcher, Harolyn Bell, JM Bell, Michael JBell, Jeneita MBelwadi, Aditya Benson, Al BBerg, H-YBerg, Robert ABerg, Robert Berger, Ian Bergstein, JBerkowitz, Steven JBerman, Jeffrey Bernhardt, Jay MBerrigan, Lindsay Betancourt, Laura MBethel, Tracy Bevans, Katherine BBhatia, EBieber, Eric JBilaniuk, Larissa TBin, Steven Bin Zahid, Abdullah Bishnoi, Ram Blackstone, Mercedes MBlanchard, Deena Blaskey, Lisa Bloom, Sandra L.Bloy, Luke Blum, Nathan JBlume, Heidi KBluthenthal, Ricky Blutinger, Erik JBohinski, JBohman, Katarina Boivin, J FBolte, John HBonfiglio, Dana Bonfiglio, Dana Bonifacio, Erin Bonsu, JM Bosquet Enlow, Michelle Bostrom, Ola Boulet, John Bradshaw, Ayana SBradshaw, Catherine P.Branas, Charles CBrawner, BM Brawner, Bridgette MBreiding, MJ Breiding, Matthew JBriggs, Ernestine CBright, Mary AnneBrilliant, Anna NBrown, Daniel PBrown, Gregory K.Browne, Kevin DBruce, Marta MBryant-Stephens, TBui, Eric Bull, Marilyn JBull, M JBurns, Michele MBurstein, Brett Burton, Leslie ABurton, LButler, Lucas Buttenheim, Alison MBuzaglo, Joanne Cahill, AM Calello, Diane PCalhoun, Deane Calkins, Monica ECallahan, James MCalne, D BCampbell, Marie Carey, Meghan ECarr, Brendan GCaruso, Carolyn Castner, Thomas Catallozzi, Marina Cegala, Donald JChaivous, J Chamberlain, Samuel Charap, Ellen SpeckerCharlton, Judith Charlton, Judith LChen, I GChen, Irene Chen, Irene GCheney, Rose ACheng, Tina LChester, Mikhail VChristian, Cindy WChute, Douglas Ciesla, Jeffrey Ciesla, Jeffrey ACirilli, Carla Clawson, Kathleen Clements, CCnaan, Avital Cnaan, ACofer, JCohen, JCohen, Akiva SCohn, Jennifer MCollins, Ronan Collins, Michael Collins, Michael ACommins, Seán Committee on Injury, Violence, and Poison PreventionCommittee on Pediatric Emergency MedicineConour, Cecily Constans, Eric Conway, Alexandra TCooper, John Corbin, Theodore JCornejo, Rebecca ACoronado, Victor GCorregano, Lauren MCorregano, LM Corwin, Daniel JCorwin, Daniel Costigan, T.E. Coughlin, Katherine Coupet, Edouard Cowell, JM Cox, T ACraig, William Craig, Matthew Crandall, J RCrandall, Jeff RCreed, Torrey Crick, Nicki RCronholm, Peter FCrookes, D Cross, Suzanne LCross, Suzanne Cuadra, Anai Culhane, Dennis PCulhane, Dennis Cullen, Kacy Culyba, Alison JCulyba, Alison Cunningham, Rebecca Curry, A ECurry, Allison ECurry, Allison ECurtis, Sarah Cutuli, J JD'Alonzo, Bernadette ADahle, Eric Dahle, Eric Dalgleish, Tim Daly, Brian PDaly, Lauren Dammavalam, Vikalpa MDamon, Andrew Darlow, Susan Datner, E MDatner, Elizabeth MDavis, Stacy NDavis, Martha BDavis, S Davis, Martha Davis, Daniela HDeatrick, Janet ADelahanty, Douglas LDelgado, Kit MDenardo, Matthew BDennis, Durbin RDennis, Nate JDenysenko, Lex DePadilla, Lara Deshpande, Sameer KDevarajan, Karthik Diamond, Guy SDiamond, Guy Dicker, Rochelle Diefenbach, Michael Diefenbach, Michael ADipiero, Marissa DiPietro, Anna Dixon, Clare Doan, Quynh Dodd, Andrew BDolan, Margaret ADonlon, K ADonlon, Katharine ADonoghue, Aaron Donoghue, A JDonoghue, Aaron JDorsch, Andrea Douglas, Ethan CDoupnik, Stephanie KDrago, D ADraus, John MDress, Erich MDrews-Botsch, Carolyn DS, Caplow-Munro Dubrow, Robert Durbin, Dennis RDurbin, Dennis Duvoisin, R CDuyck Woolf, KDV, McGehee Eagan-Brown, Brenda LEagle, Audrey Eagle, Audrey Edgar, Christopher Edwards, Marcy AEgleston, Brian LEhlers, Anke Eilevstjønn, Joar Elliot, Michael RElliott, Michael RElliott, M RElliott, Michael RElliott, MElliott, Michael Ellis, Michael Elzarka, Ayya Engel-Rebitzer, Eden Eppich, Walter JErkoboni, Danielle Esposito, Jeremy Evans, Susan LEverett, JFargo, Jamison Fargo, Jamison DFargo, Jamison DFein, Joel Fein, Seth Fein, Joel AFein, Joel AFeinberg, Betsy EFerguson, Rennie WFernandez, M Feudtner, Chris Fiks, Alexander GFischer, Kyle RFishe, JN Fisher, D LFisher, Donald LFisher, DL Fisher-Thiel, MFitzGerald, Patrick Flamma, J CFlannagan, Carol AFleisher, Linda Fleisher, Courtney Landau Fleming, Michael FFlibotte, John Flynn, Kalen Folweiler, Kaitlin AForke, Christine MForman, Jason Fortes, Jose AFoss, Robert DFraser, Andrew MFrasso, Rosemary Freedman, Melanie AFreedman, Stephen Frisch, Keri Funk, Jeanne BGaetz, William Gagnon, Isabelle Gallagher, P RGallaway, Michael García-España, Felipe Garcia-España, Felipe Garcia-España, Felipe JGarcia-España, J FGarcía-Espaňa, Felipe JGarcía-España, Felipe JGarcia-Espana, Felipe Garrido-Hernansaiz, Helena Gavin, Maureen Gaw, Christopher EGehring, Wendy Ghati, Yoganand Gibbon, M.C. Gibbons, Chris Gillan, J SGillich, Patrick JGinsburg, Kenneth RGinsburg, K RGinsburg, Kenneth Ginsburgh, Kenneth Giri, Veda NGittelman, Michael AGiummarra, Melita JGiummarra, Melita JGold, Jeffrey IGoldstein, Jesse AGoldzweig, IGolinelli, Daniela Gomes, MGonzales, Avelino J.González, Evelyn Gonzalez, Avelino Gonzalez, E Good, Grace Goodman, Arlene MGoodman, Arlene Goodwin, Arthur HGordon, Thomas FGouweloos, Juul Gouweloos, Juul Gouweloos-Trines, Juul Grady, Sean Grady, Matthew FGrady, MF Grande, David Grather, Donna Gravel, Jocelyn Green, Heather LGreen, Bernard LeeGreene, Michael BGreenspan, Arlene IGreenspan, Arlene Gregor, Courtney A.Groeger, J AGross, Laura Grossman, Michael Gruschow, Siobhan Gruver, Rachel Guerra, Terry Gullan, Rebecca LakinGuller, Leila Guo, Wensheng Gurubhagavatula, Indira Guzzo, Thomas Haarbauer-Krupa, J Haarbauer-Krupa, Juliet Haber, Leora Hafetz, Jessica Halkyard, Katherine Halpern, Scott DHalpern-Felsher, Bonnie LHamann, Cara JHammond, Rachel Hanlon, Alexandra LHanlon, Faith MHanna, Richard Hanna, Richard Hannan, Chloe Hanson, Carol AHargarten, Stephen WHarkins-Schwarz, Mary Harner, HHarris, Erica JHarrison, Stephanie Hasegawa, Raiden BHaughey, Lexie JHauschild, Hans WHausman, Alice JHawkins, Linda AHayden, Tara UHaye, Kisha Hayes, Katie LHayes, Katie He, Jibo Heckman, Carolyn Hedrick, Holly Heindel, Gregory AHelfaer, Mark AHemmons, Jessica Henary, B Henninger, Debra Henninger, DHenretig, Fred MHiguchi, KHiguchi, Kazuo Hildenbrand, Aimee KHildenbrand, Aimee Hill, SHill, Douglas Hoffman, Benjamin DHohl, Bernadette Hollander, Judd EHolmes, John HHolmes, J HHopely, Terrence Hornik, Robert Horowitz, LHouse, Ellen MHouseknecht, Eileen Howell, David RHoysted, Claire Huang, Rex Huang, Yanlan Huang, Patty Huang, Elaine Hubbard, Molly EHumm, John RHunt, Elizabeth AHutchens, Lauren Huynh, Mary Hwang, Vivian Ittenbach, Richard Jackson, Tara DJackson, Leela Jacobsohn, Lela SJacobsohn, Lela Jacoby, Sara FJaffe, Kenneth MJager-Hyman, Shari Jain, PJames, Thea LJamieson, Patrick EJawad, Abbas FJean-Gilles, Guyrandy Jermakian, Jessica SJermakian, Jessica Steps Jermakian, J SJermakian, Jessica SJew, Olivia SJiang, Tammy Jiang, Ling Jibaja-Weiss, M Jobson, Laura Johnson, Victoria EJohnson, Brian NJohnson, SL Jones, Dakota LJones, Alyssa CJones, V Jordan, AJorge, Alexandra Juarez, PKadlowec, Jennifer Kalicka, Ewa AKallan, Michael Kallan, Michael JKallan, M JKalra, Avash Kalton, Graham Kameyoshi, Hikaru Kandadai, Venk Kandadai, Venk Kang, Yun SeokKao, Trudy Karlawish, Jason HKashem, Abyaad Kassam-Adams, Nancy Kassam-Adams, Rahim Kassam-Adams, Nancy Kassam-Adams, Rahim Katz, Michael Kaufman, Bruce Kaushal, Mayank Kay, Joseph Kazak, Anne EKazak, Anne Keddem, SKeenan, Eileen Kelz, Rachel Kenardy, Justin AKenardy, Justin Kendi, Sadiqa Kennedy, Erin Kennedy, Erin Kent, R WKent, Richard Kent, Richard WKessler, Ronni Kessler, RS Kharbanda, Anupam BKhera, Gagan SKilaru, Austin Kim, Jinyong Kim, Konny HKim, Konny HKim, Mina Kindig, Matthew King, Albert IKinsman, Sara Kinzy, Tyler GKirley, Bevan BKleber, Rolf JKleinert, Julie Kleppel, Judy BKleppel, JKlienert, Julie Knox, Lynda Koepsell, Thomas DKoepsell, Thomas Kohl, Krista LKohler, Christian GKohser, Kristen LKohser, Kristen Koplin Winston, FKoppel, Sjaan Koppers, Simon Kost, Suzanne IKreshak, A AKu, Matthew Kumar, Mahendra Kuo, Jonny Kuschner, Emily Kyle, Susan BLamp, John Landolt, Markus ALandolt, Markus ALanghan, Melissa LLau, Anthony Lavelle, Jane Lavine, L LaVoie, Noelle LaVoie, Noelle Lawrence, Bruce ALe Brocque, Robyne Leddy, John JLee, Robert Lee, Yi-Ching Lee, Yi-Ching Lee, L ALeff, Stephen SLeffelman, Jessica Lefler, Elizabeth KLeonard, Henrietta LLepore, F ELessley, David Lessley, David JLevy, Suzanne Liao, ELieberman, Adina Lieberman, Leslie Lin, Richard JLincoln, Andrew ELipkind, Heather SLiu, Song Liu, Tasnuva Localio, A RLocalio, Russell ALocalio, Russell Locey, Caitlin MLockyer, Julia Loeb, Helen Loeb, Helen Long, Leann Long, Leann Longhitano, Douglas Lopez-Valdes, Francisco JLovsund, Per Lowenstein, Margaret Luberti, AA Lumba-Brown, Angela Lund, Adrian KLutz, Nicolas Lyons, Michael SLyttle, Mark DMacDonald, John MacDonald, John MMacEvoy, Julie Paquette Mackay, Murray MacKenzie, E JMacKinney, Taryn Magruder, Kathryn MMaltese, Matthew RMaltese, Matthew RManne, Sharon Manning, Cheri Mannix, Rebekah March, Sonja Marcus, Al Marcus, Alfred CMargulies, Susan SMari-Gowda, Shresta Marigowda, SMarsac, Meghan LMarsac, Meghan LMartinez, Daniel Martinez, Daniel Master, CL Master, Christina LMaster, Stephen RMaster, Christina LMathews, Emily AMatte, Thomas Mattice, JMayer, Andrew RMayer, Andrew Mayhew, Daniel RMayhew, DR Mayne, Stephanie LMcBride, Emma McCarley, Jason SMcCartt, Anne TMcCartt, A McDarby, J VMcDonald, Catherine CMcDonald, Catherine CMcGar, A McGehee, Daniel VMcGinley, Alexander DMcGrath, M EMcGrath, Caitlin McKenna, Christine McKeown-Conn, Nancy McKinnon, Anna McMahon, Patrick McMurry, Timothy LMcVeigh, Katharine HMeckler, Garth DMeehan, William PMegariotis, James Meier, Timothy BMeisel, Zachary Meisel, Zachary FMeiser-Stedman, Richard Meissner, Uwe Mello, Michael JMelzer-Lange, Marlene DMenon, Rajiv AMenon, R AMenon, Rajiv Menon, RMeropol, Neal JMetheny, Hannah Metheny, Hannah EMetzger, Kristina BMetzger, Kristi Metzger, K BMietus, Constance JMillard, Jennifer Miller, Elizabeth Miller, S Miller, Suzanne MMiller, V AMiller, Jordan EMiller, Ted RMiller, Dawn MMiller, Victoria AMiller, Gwenyth JMiloradovich, J Mirman, Jessica HMirman, JH Mirman, Daniel Mirman, Jessica HMittal, Manoj KMoll, Elisa KMoll, E KMollen, Cynthia JMollen, C JMollen, Cynthia JMong, D AMonopoli, John Montaño, Zorash Moore, Dirk Morgan, Richard MMorra, Marion EMorra, Marion Morris, S DMorris, Shannon DMorrison, Melissa Moufarrej, Sacha Muñoz, Cynthia Munro, Melissa AMunshi, Teja Murad, Mohannad Murray, Carol Myers, Rachel KNadel, Frances MNadkarni, Vinay MNadkarni, Lauren Nadkarni, Vinay Nagele, Drew ANahlik, Matthew JNance, Michael Nance, Michael LNecowitz-Hoffman, Beth Nelson, Kristen LNelson, Kyle ANelson, Deborah B.Nguyen, E Nicholls, Elizabeth Niles, Dana ENiles, Dana Nishisaki, Akira Nixon, Reginald D VNorris, CNorris, Marisol SNysaether, Jon Nysæther, Jon O'Donnell, Katherine AO'Neil, Joseph O'Neill, Desmond Obeid, Elias Olff, Miranda Ontanon, Santiago Orwin, Robert Osterhoudt, Kevin COstrowski-Delahanty, Sarah Ostrowski-Delahanty, S Otoya, LOtto, Nicole Ouimet, M COzanne-Smith, Joan Pachter, Lee MPailler, Megan EPalakshappa, Deepak Palermo, Tonya MPalmieri, Patrick APalmisciano, Lynne MPalumbo, Aimee JParent, Daniel PPark, Myung SPark, Yong Park, Grace Parker, James Parker, James Parri, Niccolò Pas, Elise T.Pasek, Josh Paskewich, Brooke Paterno, Rosalia Patterson, Matt Pedder, Jocelyn Pediatric Emergency Care Applied Research Network (PECARN)Pediatric Emergency Care Applied Research Network PECARNPediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics (PEMCRC)Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics PEMCRCPediatric Emergency Research Canada (PERC)Pediatric Emergency Research Canada PERCPediatric Emergency Research in the United Kingdom and Ireland (PERUKI)Pediatric Emergency Research in the United Kingdom and Ireland PERUKIPediatric Emergency Research Networks (PERN)Pediatric Emergency Research Networks PERNPediatric Research in Emergency Departments International Collaborative (PREDICT)Pediatric Research in Emergency Departments International Collaborative PREDICTPeek-Asa, Corinne Penn, Joseph VPenque, Michelle Perrone, Jeanmarie Pfeiffer, Melissa RPfeiffer, Melissa RPiesse, Andrea Pintar, Frank APipkorn, Bengt Podolak, Olivia Pollatsek, A PPoole, David Posner, J CPosner, Jill CPosner, JPower, Thomas JPower, T.J. Power, Thomas JPower, Thomas Prabahar, Abhiti Pradhan, APradhan, Anuj KPrice, Janet PPropert, Kathleen JPutt, Mary EPuzino, Kristina Qiu, Maylene KefengQuinlan, Kyran PQuistberg, Alex DRabinowitz, Amanda RRagsdale, Lindsay BRaich, Peter CRains, Mark Raivitch, Stephanie Raivitch, S Ramsdell, KD Ramsdell, Katharine DonlonRatcliffe, Sarah JReed, Matthew PReed, RResearch in European Pediatric Emergency Medicine (REPEM)Research in European Pediatric Emergency Medicine REPEMRhine, Tara Rich, John ARichmond, T RRichmond, Therese SRichmond, Therese SRidella, Stephen ARiley, Patrick Rineer, CRitterband, Lee Rivara, Frederick PRivers, Brian MRoach, Nancy Roan, Carol LRoberts, Kathryn ERoberts, Timothy P LRoberts, DRobinson, Roni LRobinson, Andrew Roche, Richard A PRodoletz, Michele Rodríguez-Rey, Rocío Roehler, Douglas RRogers, Rachel Rogers, Mary Romer, Dan Romer, Daniel Romer, Daniel Romer, Dan Romoser, Matthew R ERomoser, ME Ropka, Mary ERopka, Mary Rork, Kristine Ross, James GRoss, Judith LRoss, Eric ARouhana, S WRourke, Mary Rouxiang, Cao Roy, Amy DRubin, David MRuggieri, Dominique GRunge, Jeffrey Russell, Kelly Rusten, Cheryl Rustveld, L.O. Ruth, Karen JRutherford, George WRuzek, Sheryl BurtRyan, LM Ryerson, Megan SRzucidlo, Susan S, Chamberlain Saffioti, Jami Samadani, Uzma Samuel, Sandy Samuels, Marina Samuels, Marina ASandsmark, Danielle KSauber-Schatz, Erin KSaulsgiver, Kathryn ASaxe, Glenn Scarfone, Steven RScheiman, Mitchell Scherr, Sebastian Schlundt, D GSchmidt, Lyndsay RSchneider, Stephanie Schneider, Kathryn Schulman, Kevin ASchultheis, Maria TSchultheis, Maria Schultz, Robert TSchwab, William CSchwartz, Sanford JSchwarz, D FSchwarz, Donald FSeacrist, Thomas Seacrist, Thomas SSeacrist, Thomas Seacrist, Thomas SSeegan, Paige Seegan, P Seiden, Jeffrey ASeifert, Sara JSeifert, Sara Senserrick, Teresa MSenserrick, T MSetubal, Claudia Shaff, Nicholas AShaik, Aleesha Shaikh, M Shapiro, Edward SShapiro, Eugene DShaw, K NShen, M Sherman-Slate, ESherwood, Christopher PSherwood, C PShofer, Frances SShofer, F SShope, J TShope, Jean TSiegel, John HSimons-Morton, Bruce GSimons-Morton, BSimpson, Edith MSingh, Aadarsh Sisti, Dominic ASlamon, Rachel ESlamon, R Slopen, Meredith ESlouf, Kimberly Sluys, Kerstin PrignitzSmall, Dylan SSmith, W ASmith, Robert JSmith, Rebecca Smith, Douglas HSmith, RSmith, Joyce ASmith, AJ Smith, Patrick Snodgrass, Sam Solarino, Nicholas Sommers, Marilyn SSommers, Benjamin DSommers, Marilyn SSorenson, WSpicer, Rebecca SSpiro, David MSprang, Ginny St Lawrence, Schuyler Stacey, Stephen Stacey, SStafford, Perry WStanley, Rachel Stanton, Annette LStawicki, Peter SSteele, J CStephenson, David Sterner, Robert Stineman, Margaret GStineman, Margaret GStinson, NStitzel, Joel DStokes, Robert JStorey, Eileen PStraus, Jacob AStrother, Marshall Strotmeyer, Stephen Stryjewski, Glenn RSuelzer, Elizabeth MSullivan, Cris MSulmasy, Daniel Sultana, Nahida Sutton, Robert MSutton, Robert Swope, Jennifer Sykes, Emily T, Dovydaitis Tabatabaei, Andrew Talwar, Ruchika Tam, Vicky Tam, Vicky WTamborra, Nicholas Tanenbaum, Jason Tanenbaum, Jason BTanenbaum, Jason BTanji, Hiro Tanji, HTanji, Hiromasa Taylor, Daniel RTefft, Brian CTeitelman, Anne Temkin, Nancy Temkin, Nancy RTen Have, Thomas RTeoh, Eric RThiel, Megan FisherThomas, Duane EThomas, NThomas, Nicole Thomas, Nicole AThomsen, Chris Thoresen, Siri Thorpe, Lorna ETien, Allen Tien, Allen YTillson, G Topjian, Alexis Trella, Jeanette DTremoulet, Patrice DTrinastic, Jonathan Trunzo, Carrie PurbeckTushak, Sophia Tyler, Mark PTyler, Mark PTylko, Suzanne Vaca, Federico Vaca, F EVaccaro, Monica JVan Allen, Jason Van Allen, J Van Der Westhuizen, Claire Van Pelt, Amelia E.Vaughn, Nicole AVavilala, Monica SVega, Laura Vernau, Brian TVinsel, Anne Vivarelli, C MVivarelli-O'Neill, Cara Vrecenak, Jesse Vries, A PVu, TWaanders, C Waasdorp, Tracy EvianWacholder, SWade, Roy Walker, Lorrie Walsh, Susan AWalshe, Elizabeth AWalton, Maureen Wang, Wenli Wang, Jin Wanner, Katherine JWard, Chelsea Ward, Kristen Ward, Christina Watson, Peter Weaver, Ashley AWebster, Jessica LWeinberg, David SWeinfurt, Kevin PWeiss, Danielle Weiss, D Weiss, Harold BWeiss, Danielle Weiss, Eve Wen, KY Wen, Kuang YiWen, Kuang-Yi Werner, J VWertz, Christopher JWhyte, John Widaman, Keith Widaman, Keith FWidaman, Keith FWiebe, Douglas JWiebe, Douglas JWilcox, Holly CWilliams, Allan FWilliams, Thalia Williams, A FWilson, Kim Winston, Zachary Winston, Zachary Winston, Flaura Koplin Winston, Flaura KWinston, Flaura Winston, Flaura KWinston, Andrew Wintersteen, Matthew BWirtalla, Christopher Wisniewski, Steven RWissow, Lawrence Wodzin, Elaine Wofford, Kathryn LWolf, John AWolk, Courtney BenjaminWoodburn, Elizabeth MWoodlock, Joseph Woods, William Worsley, Diana Wozniak, Samantha Xavier, Angela MXia, Leilei Xie, Dawei Xiong, Guoxiang Yan, Albert CYang, Haodong Yang, King HYang, Christopher CYeates, KO Yerys, Benjamin EYerys, B Yerys, Benjamin EYoganandan, NYoganandan, Narayan Yule, William Zablotsky, Benjamin Zakrzewski, Debra Zazyczny, Kelly Ann Zeber, John E.Zelikovsky, Nataliya Zemek, Roger Zhang, Xuemei Zhang, Xuemei Zhao, Huaqing Zhao, Songzhu Zhu, Motao Ziemba, Justin Zonfrillo, Mark RZonfrillo, MR Zonfrillo, Mark RZorc, Joseph J


Triangle Locksmith in Port Neches, TX with Reviews - YP.com\nPort Neches, TX Triangle Locksmith\n4. Gilbeaux's Towing\n5. Dixie Safe And Lock\n6. Just In Time Lock and Key\n7. Bruce's Locksmith\n8. Cokers Door & Moulding\n9. Beaumont Locksmith Co.\n10. Lock&Smith INC Lumberton\n11. Best Safe & Lock\n13. Rayon Locksmith\n14. Lock & Smith Inc\n15. Benard Locksmith Service\n17. Benoit Locksmith Service 24/7\n18. Noack Locksmith And Supply Inc\n19. Jim Dandy Car Unlocking Service\n20. Bridge City Lock & Key\n22. Benoit Lock Services\n9999 Bayou Din Drbeaumont, TX 77705


Appli-Trap Appli Trap Vol. 2 Ch. 9 Andare in pensione, Appli-Trap Appli Trap Vol. 2 Ch. 9 Andare in pensione Page 2 - Niadd


SBAU Seoul Biennale 2019 | Bengal Institute for Architecture, Landscapes and Settlements SBAU Seoul Biennale 2019 – Bengal Institute for Architecture, Landscapes and Settlements\nSBAU Seoul Biennale 2019\nSeoul Biennale of Architecture and Urbanism 2019 Bengal Institute\nA visitor at the Bengal Institute's installation "Dhaka: A Million Stories," at the Seoul Biennale of Architecture and Urbanism 2019. Installation designed and curated by Salauddin Ahmed, Photo by Tae Yoon Kim.\nPrevious Previous post: সবুজের অন্বেষণে 03\nNext Next post: Armenian Church


Author anyAbdallah, TAbdel-Kader, M HAbdelhafiz, A AAbdellah, A MAbdoon, A SAdbel-Ghani, Nour TAdibi, AAfifi, M MAgarwal, AAhmad, TS Ahmad, Samera Ahmadi, Temer SAhmed, S MAioub, MAioub, Mena SAkhtari, K. Al-Abd, A MAl-Ashqar, Eal.Alabbady, A. Alamgir, F MAlamgir, FAlamgir, Faisal MAli, HR Ali, M R KAli, Moustafa RK Ali, M.R. Alizadeh, R.H. Alkilany, A MAllam, Nageh KAllam, N KAllam, Nageh AlQaradawi, S YAmbalavanan, Namasivayam Amen, K.M. Amer, A WAneja, R. Asahi, TAsiri, Abdullah MAttar, F. Austin, L AAustin, Lauren AAustin, Lauren Awad, Elias SAziz, F.M. Barry, B ABeeby, ABellamkonda, R VBiesso, ABiswas, Sushmita Blinn, KBlinn, Kevin SBoone, EBordley, JA Bordley, Justin ABottomley, L ABottomley, Lawrence ABoussac, ABräuchle, Christoph Braun, Markus Browner, Richard Bryant, JBryant, G WBunz, U H FBunz, UBurda, Clemens Burda, C. Burgin, JBurke, SCai, YCai, LCapel, Malcom Castro, DChakravarty, PChamanzar, MChang, HChávez, Jorge LChen, PChen, P CChen, JChen, Georgia Chen, XChen, DChen, K. Chen, Dongchang Chen, KCheng, SChu, L KChu, H HCohen, Marvin LCollard, D MCombs, Z ACombs, Zachary ACusanovich, M ADahmen, KDansby, K. Darugar, QDefo, B A TDel Fatti, NDevanathan, SDickerson, E BDing, YDong, BDong, JDonlan, R MDoshi, PDreaden, E CDreaden, Erik CDreaden, Erik CDrummy, Lawrence FDuan, J SEbong, AEdmonds, PEftekhar, A A ;Eisa, W HEl-Borady, Ola MEl-Nadi, L MEl-Sayed, Mostafa AEl-Sayed, I. El-Sayed, M A ;El-Sayed, M AEl-Sayed, I HEl-Sayed, M.A. El-Sayed, I HEl-Sayed, MEl-Sayed, Mostafa EL-Sayed, Mostafa AEl-Shabrawy, O AEl-Shaer, M AEl-Shenawy, S MEl‐Sayed, Mostafa AEl‐Sayed, M AEremenko, AEustis, Susie Fagerquist, Clifton KFaiad, A AFalahati, M. Fang, Y CFang, NFang, N. Farag, N MFarghali, H.A. Fathi, Shaghayegh FitzGerald, SFreitas, John EFujii, Tsuneo Fujii, TFurube, AGaddis, C SGan, D JGanzoury, M AGao, J PGao, R PGarczarek, FGarlapati, C. Garlyyev, BGarlyyev, Batyr Garmestani, HGeldmeier, J AGeldmeier, Jeffrey AGeng, JGerwert, KGetmanenko, Yulia AGhuman, K KGoodson, TGoodson III, TGreen, T CGriffiths, Jennifer AGriﬂiths, Jennifer Grobmyer, SR Gryder, B EGupta, Maneesh KHafez, AHamedani, H AHan, THasan, A. Hathcock, D JHayden, SHayden, S CHe, MHenglein, AHesabi, Z RHeyes, C DHira, S MHira, Steven MHoch, L BHolland, NHong, X MHong, X YHooshmand, NHooshmand, Nasrin Hosseinali, S.H. Hsu, H YHuang, X HHuang, Wenyu YHuang, XHuang, Xiaohua HHughes, Robert AHumphries, William HHumstoe, J OHun, MHunter, R EHwang, Hyun Jin Hwangl, Hyun Jin Ismail, K ZIsmail, Yehea Ismail, YJain, Prashant KJames, Masheika Jang, HJang, S SJeon, J -WJeon, JW Jilling, Tamas Jradi, Fadi MJung, Kwang-Woo Kageshima, Y. Kamalov, Valey FKang, KKang, Xiongwu Kang, S. Kang, Bin Kang, BKang, Bing Kelley‐Loughnane, Nancy Kerszulis, Justin Khalifa, A MKherani, N PKhoury, J TKieffer, M JKim, H TKing, John Kodiyath, Rajesh Koenig, Tobias Kondo, H. Konig, Tobias A FKönig, Tobias Konig, Tobias König, Tobias AF Kostova, I. König, Tobias Kramer, RKrylova, GLandes, Christy Landes, Christy FLandman, ULangot, PLanyi, Janos KLaurent, S. Ledin, P ALedin, Petr ALee, S MLee, Jung-Pil Lee, K SLi, YLi, X NLi, Xiaxi Li, X XLink, Stephan Lisunova, MLittle, Reginald BLiu, MLiu, Meilin Liu, A. Liu, M LLiu, CLiu, M FLiu, S YLogunov, Stephan LLoh, J YLopez-Sanchez, J.A. Lyon, L AMacheret, FMackey, Megan AMackey, M AMackey, Megan Mahmoud, M AMahmoud, Mahmoud Mahmoud, Mahmoud AMahmoud, Mahmoud. AMahmoud, MMahmoud, M.A. Mahmoud, S SMaillard, Mathieu Malak, Sidney TMarder, Seth RMarguet, SMascher, Peter Masciangioli, Tina MMascianglioli, TMasuda, Satoshi Masuhara, Hiroshi Masuhara, HMattioli, T AMcDonald, J FMilam, V TMiranda, O RMiyashita, Kyohei Mobley, James Mohamed, MB Mohamed, Mona BMolin, I U NMoran, C EMorita, Hiroshi Mousavi, S ;Mousavi, HMurali, RMurga, RMurphy, C JMwakwari, S CMwakwari, Sandra CNaik, Swati Nara, Masayuki Narasimha, SNarayanan, Radha Nashed, RNashed, Ramy Nazemi, M. Nazemi, MNear, R DNear, Rachel Near, RNegm, SNepal, Dhriti Neretina, Svetlana Nie, Shuming MNikoobakht, Babak Nishikiori, Hiromasa Nishikiori, HO'Neil, DO'Neil, Daniel Ogawa, SOsman, A.H. Ou, P. Oyelere, Adegboyega KOyelere, Adegboyega Oyelere, A KOzin, G AOzturk, RO’Neil, Daniel Pachter, RPajares, Gabriel Panikkanvalappil, Sajanlal RPanikkanvalappil, S R ;Panikkanvalappil, S.R. Panikkanvalappil, S RPark, Soojin Parker, Timothy CPeek, Mary EPeng, Xianghong HPetek, HPetroski, J MPhillips, R LPi, MPiede, J APileni, Marie-Paule Poncheri, A JPonder, J FPrausnitz, M RPreston, John SPriecel, P. Pushpanketh, SQian, WQian, Wei Qu, C. Quarles, L DQuigley, ERahman, MA Raji, Idris OReynolds, J RReynolds, K BReynolds, John RRohatgi, ARommel, Kathryn RRoselli, Cecile Rotello, V MRubio, Angel Russell, Michael Saboury, A.A. Saha, KSaira, FSalah, NSalem, H GSalihi, A. Sandhage, KSanii, L SSaxton, RSAXTON, R ESchaaff, T GSchatz, GC Schill, A WSchmidt-Krey, ISelim, S.A. Sensharma, Dilip KSetiawan, Rudi Agus Setiawan, RSetiawan, R ASeung-Soon, Jang Shabaka, A AShaheen, B SSharifi, M. Shekha, M.S. Shevchenko, Valery Shin, Dong MSilva, C. Singh, C VSmirnova, NSmith, M.J. Snyder, BSodji, Q HSong, J. Song, Li Soule, L. Sulchek, T.A. Svirko, Y PSzymanski, PSzymanski, Paul Tabor, C ETabor, CTaghizadeh, A. Takami, STalaat, M HTanaka, NTanaka, ITang, YTasumi, Mitsuo Teshima, K. Thackston, DTkachenko, Ihor MTollin, GTsukruk, Vladimir VTsukruk, V.V. Tsukruk, V VUesugi, Yohei Uesugi, YVaia, Richard AVallee, FValverde-Chávez, D.A. Van Haute, DVarnavski, O PVolkov, V VWaller, G.H. Wang, Yiqing Wang, FWang, J.H. Wang, Z LWang, Jianping Wang, Yuxiang Weng, GWhetten, R LWu, Y. Wu, YWu, Shuguang Xiong, XXiong, RYang, Difei Yassin, N AYen, C WYi, X BYoo, Seungmin Yoo, J WYoo, Seoung-Kyo Yu, S. Zewail, Ahmed Zhang, S. Zhang, NZhang, KZhang, J ZZhang, SZHANG, N Y IZhao, G XZhao, BZhelyaskov, VZhou, J. Zhou, JZou, Bingsuo S


Cape Cod House in Living Room, Family Room, Office Room, Bathroom, Kitchen, undefined\nOct. 20, 2012 by M\nADD FAVORITE Picture Windows - Tall (1,380 Size + Finish Combinations Available)\nDIMENSION: 96w 56d 4h (in.)\nADD FAVORITE Country Fabric Sofa\nDIMENSION: 88w 32d 41h (in.)\nDIMENSION: 43w 32d 38h (in.)\nADD FAVORITE Garage Door\nDIMENSION: 96w 84d 4h (in.)


Free to Good Home Chihuahua- Daschund Mix Female 10 yrs old 378-9629 Carpet/Vinyl/Tile/Wood Install...\nCarpet/Vinyl/Tile/Wood Installation 45 + yrs exp. Restretch specialist 947-4061 #iderc*066nh ESTATE SALE, 40 + years accum...\nBuying/selling a home? Desert Hills Realty Rick McBride 947-4748 HomesByRick.net FREON 12


1C4GP45R65B270287, Bidding ended on 2005 blue Chrysler Town & Cou - AutoBidMaster Welcome, Guest! Log In\nRover Lexus Lincoln Mazda Mercedes-Benz Mitsubishi Nissan Pontiac Subaru Toyota Volvo Volkswagen All Makes Types of Vehicles Automobiles SUVs Pickup Trucks Motorcycles Classics RVs ATVs Dirt Bikes Heavy Duty Industrial Trailers Boats Jet skis Snowmobiles No Damage Clean Titles Repossessions Recovered Thefts Exotics Rentals Runs & Drives Flood Damage Donations Impound Vehicles Vandalism Hail Damage Pure Sale Items Buy It Now Auction Calendar Vehicle Locations Live Auctions Shipping How to Buy How to Buy FAQ Rules and Policies Bidding Tips FREE MEMBERSHIP30 Day Trial Home Vehicle Finder Cars Chrysler Town & Cou 2005 Chrysler Town & Cou Back to Search Results Previous Lot Next Lot Notifications: off Add to Watchlist Lot # 360927962005 CHRYSLER TOWN & COU 3.3L 6 for Sale at Copart Auto Auction\nTHIS VEHICLE IS BEING SOLD AS "AS IS - WHERE IS" - ALL BIDS ARE BINDING AND ALL SALES ARE FINAL What this means PREV IMAGE LARGE IMAGES ZOOM x2 NEXT IMAGE Copart Auto Auction CHRYSLER Lot Details Lot # 36092796 Est. Retail Value $3,759 USD Repair Est $5,151 USD Ownership Doc Type FL - CERT OF TITLE-SLVG&SLVG REBILD Odometer 83,545 ACTUAL Primary Damage FRONT END Color BLUE Engine 3.3L 6 Drive Front-wheel Drive Cylinders 6 Fuel GAS Keys YES Auction Verification Run & Drive Verified Bid Information Auction Location Tampa South, FL show on map Sale Date Friday, December 2, 2016 Live Auction Starts 08:00 AM Pacific Standard Time Live Auction Item Lane D - Item # 4133\nShowing 12 of 1,076 2005 CHRYSLER TOWN & COU Auction: Billings, MT Current Bid:\n$0 USD 2001 CHRYSLER TOWN & COU Auction: Indianapolis, IN Current Bid:\n$0 USD 2011 CHRYSLER TOWN & COU Auction: Atlanta North, GA Current Bid:\n$0 USD 2006 CHRYSLER TOWN & COU Auction: Colorado Springs, CO Time Left:\n$0 USD 2007 CHRYSLER TOWN & COU Auction: Scranton, PA Current Bid:


DANDY-732 Slut And Rainy Day Alone On The Last Train! When I Erected By The Temptation Of A Hollow Drunk Beautiful Leg Woman Who Underwear In The Opposite Seat, I Was Fucked\namateurhigh visiondandyolder sisterjavslendercensoredslut DANDY-732DANDY732DANDY\nfull jav movies dandy-732, dandy732, dandy, 1dandy00732 DANDY-732 Slut And Rainy Day Alone On The Last Train! When I Erected By The Temptation Of A Hollow Drunk Beautiful Leg Woman Who Underwear In The Opposite Seat, I Was Fucked pantyhose, older sister, slender, hi def, slut , jav full movie DANDY-732 DANDY732 DANDY


As the holy month begins, the High Commissioner shared a video touching on the plight of millions displaced by conflict.\nBy UNHCR | 06 June 2016 | Español | Français\nUN High Commissioner for Refugees Filippo Grandi visits with a family of Syrian refugees in Beirut in January 2016. © UNHCR/Bryan Denton


FFAS03 results for O95838\nresults for: O95838\nQuery: sp|O95838|GLP2R_HUMAN Glucagon-like peptide 2 receptor OS=Homo sapiens GN=GLP2R PE=1 SV=1, from H.sapiens\n# Score Template Links and tools %id First MKLGSSRAGPGRGSAGLLPGVHELPMGIPAPWGTSPLSFHRKCSLWAPGRPFLTLVLLVSIKQVTGSLLEETTRKWAQYKQACLRDLLKEPSGIFCNGTFDQYVCWPHSSPGNVSVPCPSYLPWWSEESSGRAYRHCLAQGTWQTIENATDIWQDDSECSENHSFKQNVDRYALLSTLQLMYTVGYSFSLISLFLALTLLLFLRKLHCTRNYIHMNLFASFILRTLAVLVKDVVFYNSYSKRPDNENGWMSYLSEMSTSCRSVQVLLHYFVGANYLWLLVEGLYLHTLLEPTVLPERRLWPRYLLLGWAFPVLFVVPWGFARAHLENTGCWTTNGNKKIWWIIRGPMMLCVTVNFFIFLKILKLLISKLKAHQMCFRDYKYRLAKSTLVLIPLLGVHEILFSFITDDQVEGFAKLIRLFIQLTLSSFHGFLVALQYGFANGEVKAELRKYWVRFLLARHSGCRACVLGKDFRFLGKCPKKLSEGDGAEKLRKLQPSLNSGRLLHLAMRGLGELGAQPQQDHARWPRGSSLSECSEGDVTMANTMEEILEESEI Last\n1 -120.000 sp|O95838|GLP2R_HUMAN Glucagon-like peptide 2 receptor OS=Homo sapiens GN=GLP2R PE=1 SV=1 ali 100 1 MKLGSSRAGPGRGSAGLLPGVHELPMGIPAPWGTSPLSFHRKCSLWAPGRPFLTLVLLVSIKQVTGSLLEETTRKWAQYKQACLRDLLKEPSGIFCNGTFDQYVCWPHSSPGNVSVPCPSYLPWWSEESSGRAYRHCLAQGTWQTIENATDIWQDDSECSENHSFKQNVDRYALLSTLQLMYTVGYSFSLISLFLALTLLLFLRKLHCTRNYIHMNLFASFILRTLAVLVKDVVFYNSYSKRPDNENGWMSYLSEMSTSCRSVQVLLHYFVGANYLWLLVEGLYLHTLLEPTVLPERRLWPRYLLLGWAFPVLFVVPWGFARAHLENTGCWTTNGNKKIWWIIRGPMMLCVTVNFFIFLKILKLLISKLKAHQMCFRDYKYRLAKSTLVLIPLLGVHEILFSFITDDQVEGFAKLIRLFIQLTLSSFHGFLVALQYGFANGEVKAELRKYWVRFLLARHSGCRACVLGKDFRFLGKCPKKLSEGDGAEKLRKLQPSLNSGRLLHLAMRGLGELGAQPQQDHARWPRGSSLSECSEGDVTMANTMEEILEESEI 553\n2 -97.200 sp|Q03431|PTH1R_HUMAN(removed signalp:1-28) Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Homo sapiens GN=PTH1R PE=1 SV=1 ali follow.. 28 39 .......................................................KGWTSASTSGKPRKDKASGKLYPESEEDKEAPTSRYRGRPCLPEWDHILCWPLGAPGEVVAVPCPDYI-YDFNHKGHAYRRCDRNGSWELVPGHNRTWANYSECVKFLTNETRE--REVFDRLGMIYTVGYSVSLASLTVAVLILAYFRRLHCTRNYIHMHLFLSFMLRAVSIFVKDAVLYSGATLDEAEAPPPPATAAAGYAGCRVAVTFFLYFLATNYYWILVEGLYLHSLIFMAFFSEKKYLWGFTVFGWGLPAVFVAVWVSVRATLANTGCW-DLSSGNKKWIIQVPILASIVLNFILFINIVRVLATKLRETNAGRCQQYRKLLKSTLVLMPLFGVHYIVFMATPYTEVSGTLWQVQMHYEMLFNSFQGFFVAIIYCFCNGEVQAEIKKSWSRWTLALDFKRKARSGSSSYSYGPMVSHTSVTNVGPRVGLGLPLSPRLLPTATTNGHETLETTPPAMAAPKDDGFLNGSCSGLDEEASGPERPPALLQEEW. 561\n3 -97.100 sp|P49190|PTH2R_HUMAN(removed signalp:1-24) Parathyroid hormone 2 receptor OS=Homo sapiens GN=PTH2R PE=1 SV=1 ali follow.. 27 1 ...........................................................QLDSDGTITIEEQIVLVLKAKVQCELNITAQEGEGNCFPEWDGLICWPRGTVGKISAVPCPPYI-YDFNHKGVAFRHCNPNGTWDFMHSLNKTWANYSDCLRFLQPDISIGKQEFFERLYVMYTVGYSISFGSLAVAILIIGYFRRLHCTRNYIHMHLFVSFMLRATSIFVKDRVVHAHIGVKELESIEATSVDKSQYIGCKIAVVMFIYFLATNYYWILVEGLYLHNLIFVAFFSDTKYLWGFILIGWGFPAAFVAAWAVARATLADARCW-ELSAGDIKWIYQAPILAAIGLNFILFLNTVRVLATKIWETNAVGHDQYRKLAKSTLVLVLVFGVHYIVFVCLPHS-FTGLGWEIRMHCELFFNSFQGFFVSIIYCYCNGEVQAEVKKMWSRWNLSVDWKRTPPCGSRRCGSVLTTVTHSTSSQSQVAASTRMVLISGKAAKIASRQPDSHITLPGYVWSNSEQDCLPHSFHEETKEDSGRQGDDILMEKP. 505\n4 -94.200 sp|P47871|GLR_HUMAN(removed signalp:1-26) Glucagon receptor OS=Homo sapiens GN=GCGR PE=1 SV=1 ali follow.. 37 1 ..................................................................QVMDFLFEKWKLYGDQCHHNLSLLPTELVCNRTFDKYSCWPDTPANTTANISCPWYLWHHKVQHRFVFKRCGPDGQWVRGPRGQPWRDASQCQMDGEEIEVQKEVAKMYSSFQVMYTVGYSLSLGALLLALAILGGLSKLHCTRNAIHANLFASFVLKASSVLVIDGLLRTRYSQKIGDDLSSTWLSDGAVAGCRVAAVFMQYGIVANYCWLLVEGLYLHNLLGLATLPERSFFSLYLGIGWGAPMLFVVPWAVVKCLFENVQCWTSNDNMGFWWILRFPVFLAILINFFIFVRIVQLLVAKLRARQMHHTDYKFRLAKSTLTLIPLLGVHEVVFAFVTDEHAQGTLRSAKLFFDLFLSSFQGLLVAVLYCFLNKEVQSELRRRWHRWRLGKVLWEERNTSNHRASSSPGHGPPSKELQFGRGGGSQDSSAETPLAGGLPRLAES.......................................... 449\n5 -94.000 sp|P43220|GLP1R_HUMAN(removed signalp:1-23) Glucagon-like peptide 1 receptor OS=Homo sapiens GN=GLP1R PE=1 SV=2 ali follow.. 41 2 .............................................................PQGATVSLWETVQKWREYRRQCQRSLTEDPTDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSS-PEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS........................................................ 440\n6 -92.200 sp|P48546|GIPR_HUMAN(removed signalp:1-25) Gastric inhibitory polypeptide receptor OS=Homo sapiens GN=GIPR PE=1 SV=1 ali follow.. 38 1 ..............................................................GSKGQTAGELYQRWERYRRECQETLAAAESGLACNGSFDMYVCWDYAAPNATARASCPWYLWHHHVAAGFVLRQCGSDGQWGLWRDHTQCENPEKNEAF-------LDQRLILERLQVMYTVGYSLSLATLLLALLILSLFRRLHCTRNYIHINLFTSFMLRAAAILSRDRLLPRPGPY---LGDQALALWNQALAACRTAQIVTQYCVGANYTWLLVEGVYLHSLLVLVGGSEEGHFRYYLLLGWGAPALFVIPWVIVRYLYENTQCWERNEVKAIWWIIRTPILMTILINFLIFIRILGILLSKLRTRQMRCRDYRLRLARSTLTLVPLLGVHEVVFAPVTEEQARGALRFAKLGFEIFLSSFQGFLVSVLYCFINKEVQSEIRRGWHHCRLRRSLGEEQRQLPERAFRALPSGSGPGEVPTSRGLSSGTLPGPGNEASRELES............................................. 439\n7 -91.800 sp|P30988|CALCR_HUMAN(removed signalp:1-24) Calcitonin receptor OS=Homo sapiens GN=CALCR PE=1 SV=1 ali follow.. 20 6 .........................................................TYPTIEPKPFLYVVGRKKMMDAQYKCYDRMQQLPEGPYCNRTWDGWLCWDDTPAGVLSYQFCPDYF-PDFDPSEKVTKYCDEKGVWFKHPENNRTWSNYTMCNAFTPEKLKNASLSIFTLVISLGIFVFFRKLTTIFPLNWKYRKALSLGCQRVTLHKNMFLTYILNSMIIIIHLVEVVPN-----------GELVRRDPVSCKILHFFHQYMMACNYFWMLCEGIYLHTLIVVAVFTEKQRLRWYYLLGWGFPLVPTTIHAITRAVYFND-NCWLSVETHLLYIIHGPVMAALVVNFFFLLNIVRVLVTKMRETHEAESHMYLKAVKATMILVPLLGIQFVVFPWRPS---NKMLGKIYDYVMHSLIHFQGFFVATIYCFCNNEVQTTVKRQWAQFKIQWNQRWGRRPSNRSARAAAAAAEAGDIPIYICHQEPRNEPANNQGEESAEIIPLNIIEQESSA.................................. 466\n8 -89.000 sp|Q16602|CALRL_HUMAN(removed signalp:1-22) Calcitonin gene-related peptide type 1 receptor OS=Homo sapiens GN=CALCRL PE=1 SV=2 ali follow.. 23 2 ..........................................................LEESPEDSIQLGVTRNKIMTAQYECYQKIMQDPEGVYCNRTWDGWLCWNDVAAGTESMQLCPDYF-QDFDPSEKVTKICDQDGNWFRHPASNRTWTNYTQCN-----VNTHEKVKTALNLFYLTIIGHGLSIASLLISLGIFFYFKSLSCQRITLHKNLFFSFVCNSVVTIIHLTAVA-----------NNQALVATNPVSCKVSQFIHLYLMGCNYFWMLCEGIYLHTLIVVAVFAEKQHLMWYYFLGWGFPLIPACIHAIARSLYYND-NCWISSDTHLLYIIHGPICAALLVNLFFLLNIVRVLITKLKVTHQAESNLYMKAVRATLILVPLLGIEFVLIPWRPE---GKIAEEVYDYIMHILMHFQGLLVSTIFCFFNGEVQAILRRNWNQYKIQFGNSFSNSEALRSASYTVSTISDGPGYSHDCPSEHLNGKSIHDIENVLLKPEN........................................... 436\n9 -88.200 sp|P32241|VIPR1_HUMAN(removed signalp:1-30) Vasoactive intestinal polypeptide receptor 1 OS=Homo sapiens GN=VIPR1 PE=1 SV=1 ali follow.. 33 1 ...............................................................ARLQEECDYVQMIEVQHKQCLEEAQLENETIGCSKMWDNLTCWPATPRGQVVVLACPLIFLFSSIQGRNVSRSCTDEGWTHLEPGPYPIACGLDDKAA----SLDEQQTMFYGSVKTGYTIGYGLSLATLLVATAILSLFRKLHCTRNYIHMHLFISFILRAAAVFIKDLALFDS---------GESDQCSEGSVGCKAAMVFFQYCVMANFFWLLVEGLYLYTLLAVSFFSERKYFWGYILIGWGVPSTFTMVWTIARIHFEDYGCW-DTINSSLWWIIKGPILTSILVNFILFICIIRILLQKLRPPDISDSSPYSRLARSTLLLIPLFGVHYIMFAFFP----DNFKPEVKMVFELVVGSFQGFVVAILYCFLNGEVQAELRRKWRRWHLQGVLGWNPKYRHPSGGSNGATCSTQVSMLTRVSPGARRSSSFQAEVSLV................................................ 427\n10 -86.800 sp|P41586|PACR_HUMAN(removed signalp:1-23) Pituitary adenylate cyclase-activating polypeptide type I receptor OS=Homo sapiens GN=ADCYAP1R1 PE=1 SV=1 ali follow.. 30 4 ...........................................................................FKKEQAMCLEKIQRNDSSPGCPGMWDNITCWKPAHVGEMVLVSCPELF-RIFNPDQVWETETIGESDFGDSNSLDLSDMGVVSRGFDEYESETGDQDYYYLSVKALYTVGYSTSLVTLTTAMVILCRFRKLHCTRNFIHMNLFVSFMLRAISVFIKDWILYAEQDSNH---------CFISTVECKAVMVFFHYCVVSNYFWLFIEGLYLFTLLVETFFPERRYFYWYTIIGWGTPTVCVTVWATLRLYFDDTGCWDMNDSTALWWVIKGPVVGSIMVNFVLFIGIIVILVQKLQSPDMNESSIYLRLARSTLLLIPLFGIHYTVFAFSP----ENVSKRERLVFELGLGSFQGFVVAVLYCFLNGEVQAEIKRKWRSWKVNRYFAVDFKHRHPSLASSGVNGGTQLSILSKSSSQIRMSGLPADNLAT................................................. 445\n11 -85.700 sp|P47872|SCTR_HUMAN(removed signalp:1-27) Secretin receptor OS=Homo sapiens GN=SCTR PE=2 SV=2 ali follow.. 37 3 ...................................................................RLCDVLQVLWEEQDQCLQELSREQPVPGCEGMWDNISCWPSSVPGRMVEVECPRFLRMLTSRNGSLFRNCTQDGWSETFPRPNLACGVNVNDSS------NEKRHSYLLKLKVMYTVGYSSSLVMLLVALGILCAFRRLHCTRNYIHMHLFVSFILRALSNFIKDAVLFSS---------DDVTYCDAHRAGCKLVMVLFQYCIMANYSWLLVEGLYLHTLLAISFFSERKYLQGFVAFGWGSPAIFVALWAIARHFLEDVGCWDINANASIWWIIRGPVILSILINFILFINILRILMRKLRTQETNEVSHYKRLARSTLLLIPLFGIHYIVFAFSPEDAM-----EIQLFFELALGSFQGLVVAVLYCFLNGEVQLEVQKKWQQWHLREFPLHPVASFSNSTKASHLEQSQGTCRTSI.................................................................. 412\n12 -84.600 sp|Q13324|CRFR2_HUMAN(removed signalp:1-19) Corticotropin-releasing factor receptor 2 OS=Homo sapiens GN=CRHR2 PE=2 SV=2 ali follow.. 27 1 ...............................................................................EELLLDGWGPPGPYSYCNTTLDQITCWPRSAAGALVERPCPEYFGVKYNTTRNAYRECLENGTWASKINYSQCEPILDDKQ--------RKYDLHYRIALVVNYLGHCVSVAALVAAFLLFLALRSIRCLRNVIHWNLITTFILRNVMWFLLQLVDHEV--------------HESNEVWCRCITTIFNYFVVTNFFWMFVEGCYLHTAIVMTYSTERLRKCLFLFIGWCIPFPIIVAWAIGKLYYENEQCWFGEPGDLVDYIYQGPIILVLLINFVFLFNIVRILMTKLRASTTSETIQYRKAVKATLVLLPLLGITYMLFFVNPGE--DDLSQIMFIYFNSFLQSFQGFFVSVFYCFFNGEVRSAVRKRWHRWQDHHSLRVPMARAMSIPTSPTRISFHSIKQTAA.................................................................. 391\n13 -84.500 sp|P34998|CRFR1_HUMAN(removed signalp:1-23) Corticotropin-releasing factor receptor 1 OS=Homo sapiens GN=CRHR1 PE=1 SV=1 ali follow.. 23 1 .............................................................................SLQDQHCESLSLASSGLQCNASVDLITCWPRSPAGQLVVRPCPAFFGVRYNTTNNGYRECLANGSWAARVNYSECQEILNEEKKSKVHYHVAVILRLRPGCTHWGDQADGALEVGAPWSGAPFQVRRSIRCLRNIIHWNLISAFILRNATWFVVQLTMSPE-------------VHQSNVGWCRLVTAAYNYFHVTNFFWMFGEGCYLHTAIVLTYSTDRLRKWMFICIGWGVPFPIIVAWAIGKLYYDNEKCWFGRPGVYTDYIYQGPMILVLLINFIFLFNIVRILMTKLRASTTSETIQYRKAVKATLVLLPLLGITYMLFFVNPGE--DEVSRVVFIYFNSFLESFQGFFVSVFYCFLNSEVRSAIRKRWHRWQDKHSIRARVARAMSIPTSPTRVSFHSIKQSTA.................................................................. 420\n14 -84.400 sp|P41587|VIPR2_HUMAN(removed signalp:1-20) Vasoactive intestinal polypeptide receptor 2 OS=Homo sapiens GN=VIPR2 PE=1 SV=2 ali follow.. 31 2 ..................................................................HPECRFHLEIQEEETKCAELLRSQTKHKACSGVWDNITCWRPANVGETVTVPCPKVF-SNFYSKAGNISKNCTSDGWSETFPDFVDACGYSDPED-------ESKITFYILVKAIYTLGYSVSLMSLATGSIILCLFRKLHCTRNYIHLNLFLSFILRAISVLVKDDVLYSSSGTLHCPD------QPSSWVGCKLSLVFLQYCIMANFFWLLVEGLYLHTLLVAMLPPRRCFLAYLLIGWGLPTVCIGA-WTAARLYLEDTGCWDTNDHSVPWWVIRIPILISIIVNFVLFISIIRILLQKLTSPDVNDQSQYKRLAKSTLLLIPLFGVHYMVFAVFP----ISISSKYQILFELCLGSFQGLVVAVLYCFLNSEVQCELKRKWRSRCPTPSASRDYRVCGSSFSRNGSEGALQFHRGSRAQSFLQTETS........................................................ 416\n15 -83.300 sp|Q02643|GHRHR_HUMAN(removed signalp:1-22) Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 ali follow.. 31 3 ..................................................................HPECDFITQLREDESACLQAAEEMPTTLGCPATWDGLLCWPTAGSGEWVTLPCPDFF-SHFSSESGAVKRDCTITGWSEPFPPYPVACPVPLELL-------AEEESYFSTVKIIYTVGHSISIVALFVAITILVALRRLHCPRNYVHTQLFTTFILKAGAVFLKDAALFHS---------DDTDHCSFSTVLCKVSVAASHFATMTNFSWLLAEAVYLNCLLASTSPSSRRAFWWLVLAGWGLPVLFTGTWVSCKLAFEDIACWDLDDTSPYWWIIKGPIVLSVGVNFGLFLNIIRILVRKLEPAQGHTQSQYWRLSKSTLFLIPLFGIHYIIFNFLP----DNAGLGIRLPLELGLGSFQGFIVAILYCFLNQEVRTEISRKWHGHDPELLPAWRTRAKWTTPSRSAAKVLTS........................................................................ 399\n16 -62.600 sp|Q6QNK2|GP133_HUMAN(removed signalp:1-25) Probable G-protein coupled receptor 133 OS=Homo sapiens GN=GPR133 PE=2 SV=1 ali 18 1 .............................................................................................................................................................................................................................................................EPGTTPCQVMAVLLHYFFLSAFAWMLVEGLHLYSMVIKVFGSEDSKHRYYYGMGWGFPLLICIISLSFAMDSYGTSNCWLSLASGAIWAFVAPALFVIVVNIGILIAVTRVISQISADNYKGDPSAFKLTAKAVAVLLPILGTSWVFGVLAVNGCA-----VVFQYMFATLNSLQGLFIFLFHCLLNSEVRAAFKHKTKVWSLTSSSARTSNAKPFHSDLMNGTRPGMASTKLSPWDKSSHSAHRVDLSA.................................................. 248\n17 -61.600 sp|Q14246|EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 ali 18 1 ................................................................................................................................................................................SLYIISHVGIIISLVCLVLAIATFLLCRSIRNHNTYLHLHLCVCLLLAKTLFLAGIHKT-------------------DNKMGCAIIAGFLHYLFLACFFWMLVEAVILFLMVRNLKVSRNIKMLHICAFGYGLPMLVVVISASVQPQGYGMNRCWLNTETGFIWSFLGPVCTVIVINSLLLTWTLWILRQRLSSAEVSTLKDTRLLTFKAFAQLFILGCSWVLGIFQIGPVA-----GVMAYLFTIINSLQGAFIFLIHCLLNGQVREEYKRWITGKTKPSSQSQTSRILLSSMPSASKT............................................................................ 285\n18 -59.800 sp|Q9HAR2|LPHN3_HUMAN(removed signalp:1-21) Latrophilin-3 OS=Homo sapiens GN=LPHN3 PE=1 SV=2 ali 13 1 ..............................................................................................................................................................................................................................................................DQPIACAVFAALLHFFFLAAFTWMFLEGVQLYIMLVEVFESEHSRRKYFYLVGYGMPALIVAVSAAVDYRSYGTDKCWLRLDTYFIWSFIGPATLIIMLNVIFLGIALYKMFHHTAIPESGCLDNIKSWVIGAIALLCLLGLTWAFGLMYINEST-----VIMAYLFTIFNSLQGMFIFIFHCVLQKKVRKEYGKCLRTHCCSGKSTESSIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRKQSESSFITGDINSSASLNREGLLNNARDTSVMDTLPLNGNHGNSYSIASGEYLSN. 296\n19 -59.600 sp|P48960|CD97_HUMAN(removed signalp:1-20) CD97 antigen OS=Homo sapiens GN=CD97 PE=1 SV=4 ali 18 1 ............................................................................................................................................................................................................................................................................YCFLAAFCWMSLEGLELYFLVVRVFQGQGLSTRWLCLIGYGVPLLIVGVSAAIYSKGYGRPYCWLDFEQGFLWSFLGPVTFIILCNAVIFVTTVWKLTQKFSEPDMKKLKKARALTITAIAQLFLLGCTWVFGLFIFDDRS-----LVLTYVFTILNCLQGAFLYLLHCLLNKKVREEYRKWACLVAGGSKYSEFTSTTSGTGHNQTRALRASESG..................................................................... 214\n20 -58.800 sp|Q9HBW9|ELTD1_HUMAN(removed signalp:1-19) EGF, latrophilin and seven transmembrane domain-containing protein 1 OS=Homo sapiens GN=ELTD1 PE=1 SV=3 ali 17 1 ............................................................................................................................................................................................................................LFLAELVFLV-------------------GINTNTNKLFCSIIAGLLHYFFLAAFAWMCIEGIHLYLIVVGVIYNKGFLHKNFYIFGYLSPAVVVGFSAALGYRYYGTTKCWLSTENNFIWSFIGPACLIILVNLLAFGVIIYKVFRHTAGLKPSCFENIRSCARGALALLFLLGTTWIFGVLHVVHAS-----VVTAYLFTVSNAFQGMFIFLFLCVLSRKIQEEYYRLFKNVPCCFG.............................................................................................. 218\n21 -58.200 sp|Q8IZF5|GP113_HUMAN(removed signalp:1-25) Probable G-protein coupled receptor 113 OS=Homo sapiens GN=GPR113 PE=2 SV=1 ali 16 1 .......................................................................................................................................................................................VGLGASILALLVCLGVYWLVWRISYFRHAALLNMVFCLLAADTCFLGAPFL-----------------SPGPRSPLCLAAAFLCHFLYLATFFWMLAQALVLAHQLLFVFHQLAKHLPLMVLLGYLCPLGLAGVTLGLYLPYLREGECWLDGKGGALYTFVGPVLAIIGVNGLVLAMAMLKLLRPSLSPPAEKRQALLGVIKALLILTPIFGLTWGLGLATLLEEVS----TVPHYIFTILNTLQGVFILLFGCLMDRKIQEALRKRFCRAQAPSSTISLVSCCLQILSCASKSMSEGIPWPSSEDMG.............................................................. 300\n22 -57.200 sp|O14514|BAI1_HUMAN(removed signalp:1-30) Brain-specific angiogenesis inhibitor 1 OS=Homo sapiens GN=BAI1 PE=1 SV=1 ali 16 6 ......................................................................................................................................................................SADANMEKATLPSVTLIVGCGVSSLTLLMLVIIYVSVRYIRSERSVILINFCLSIISSNALILI-------------------GQTQTRNKVMCTLVAAFLHFFFLSSFCWVLTEAWQSYMAVTGHLRNRLIRKR-FLCLGWGLPALVVAISVGFTKAYSTMNYCWLSLEGGLLYAFVGPAAAVVLVNMVIGILVFNKLVSKDGITDKKLKERAGASLWSSCVVLPLLALTWMSAVLAVTDRRS----ALFQILFAVFDSLEGFVIVMVHCILRREVQDAVKCRVVDRQEEGNGDSGGSFQNGHAQLMTDFEKDVD....................................................................... 300\n23 -56.700 sp|Q5T601|GP110_HUMAN(removed signalp:1-19) Probable G-protein coupled receptor 110 OS=Homo sapiens GN=GPR110 PE=2 SV=2 ali 16 1 ..............................................................................................................................................................................................................SHTRRICMVNIALSLLIADVWFIVGATV----------------DTTVNPSGVCTAAVFFTHFFYLSLFFWMLMLGILLAYRIILVFHHMAQHMAVGFCLGYGCPLIISVITIAVTYKRKDVCWLNWSNGSKPLLAFVVPALAIVAVNFVVVLLVLTKLWRPTVGERLDDKATIIRVGKSLLILTPLLGLTWGFGIGTIVDSQN----LAWHVIFALLNAFQGFFILCFGILLDSKLRQLLFNKLSALSSWKQTEKQNSSDLSAKPKFSKPFNPLQNKGHYAFSHTGDSSDNIMLTQFVSNE............................................. 291\n24 -56.700 sp|Q9HCU4|CELR2_HUMAN(removed signalp:1-31) Cadherin EGF LAG seven-pass G-type receptor 2 OS=Homo sapiens GN=CELSR2 PE=1 SV=1 ali 14 2 .............................................................................................................................................................................................................................................................ADLPFACTVIAILLHFLYLCTFSWALLEALHLYRALTEVRDVNTGPMRFYYMLGWGVPAFITGLAVGLDPEGYGNPDFCWLSYDTLIWSFAGPVAFAVSMSVFLYILAARASCAAQR--QGFEKKGPVSGLQPSFAVLLLLSATWLLALLSVNSDT-----LLFHYLFATCNCIQGPFIFLSYVVLSKEVRKALKLACSRKPSPDPALTTKSTLTSSYNCPSPYADGRLYQPYGDSAGSLHSTSRSGKSQPSYIPFLLREESALNPGQGPPGLGDPGSLFLEGQDQQHDPDTDSDSDLSL 295\n25 -54.600 sp|Q8IZF2|GP116_HUMAN(removed signalp:1-22) Probable G-protein coupled receptor 116 OS=Homo sapiens GN=GPR116 PE=1 SV=3 ali 17 8 .............................................................................................................................................................................................................................................................ILCKTACVAATFFIHFFYLSVFFWMLTLGLMLFYRLVFILHETSRSKAIAFCLGYGCPLAISVITLGATQYTRKNVCWLNWEDTKALLAFAIPALIIVVVNITITIVVITKILRPSIGDKPQEKSSLFQISKSIGVLTPLLGLTWGFGLTTVFPGTN----LVFHIIFAILNVFQGLFILLFGCLWDLKVQEALLNKFSLSRWSSQHSKSTSLGSSTPVFSMSSPISRRFNNLFGKTGTYNVSTPEATSSSLENSSSASS........................................ 271\n26 -54.000 sp|O95490|LPHN2_HUMAN(removed signalp:1-25) Latrophilin-2 OS=Homo sapiens GN=LPHN2 PE=1 SV=2 ali 10 1 ...................................................................................................................................................................................................................................................................................AWMCLEGVQLYLMLVEVFESEYSRKKYYYVAGYLFPATVVGVSAAIDYKSYGTEKCWLHVDNYFIWSFIGPVTFIILLNIIFLVITLCKMVKHSNTPDSSRLENIKSWVLGAFALLCLLGLTWSFGLLFINEET-----IVMAYLFTIFNAFQGVFIFIFHCALQKKVRKEYGKCFRHSYCCGGLPTESPHSSVKASTTRTSARYSSGTQSRIRRMWNDTVRKQSESSFISGDINSTSTLNQGMTGNYLLTNPLLRPHGTNNPYNTLLAETVVCNAP. 275\n27 -53.500 sp|Q8IZF3|GP115_HUMAN(removed signalp:1-21) Probable G-protein coupled receptor 115 OS=Homo sapiens GN=GPR115 PE=2 SV=3 ali 17 2 ...................................................................................................................................................................................................................................................................CVAVTFFSHFFYLSLFFWMLFKALLIIYGILVIFMMKSRMMVIGFAIGYGCPLIIAVTTVAITEYMRPEACWLNWDNTKALLAFAIPAFVIVAVNLIVVLVVAVNTQRSIGSSKSQDVVIIMRISKNVAILTPLLGLTWGFGIATLIEGTS----LTFHIIFALLNAFQGFFILLFGTIMDHKIRDALRMRMSSLKGKSRAAENASLGPTNGSKLMNRQG.......................................................................... 224\n28 -52.100 sp|O94910|LPHN1_HUMAN Latrophilin-1 OS=Homo sapiens GN=LPHN1 PE=1 SV=1 ali 16 1 ..........................................................................................................................................................................................................................INLFLAELLFLV-------------------GIDKTQYEIACPIFAGLLHYFFLAAFSWLCLEGVHLYLLLVEVFESEYSRTKYYYLGGYCFPALVVGIAAAIDYRYGTEKACWLRVDNYFIWSFIGPVSFVIVVNLVFLMVTLHKMIRSSSVPDSSRLDNIKSWALGAIALLFLLGLTWAFGLLFINKES-----VVMAYLFTTFNAFQGVFIFVFHCALQKKVHKEYSKCLRHSYCCIRSPPGGTHGSLKTSAMRSNTRYYTGTQSRIRRMWNDTVRKQTESSFMAGDINSTPTLNRGTMGNHLLTNPVLQPRGGTS................ 298\n29 -51.600 sp|Q9NYQ7|CELR3_HUMAN(removed signalp:1-31) Cadherin EGF LAG seven-pass G-type receptor 3 OS=Homo sapiens GN=CELSR3 PE=1 SV=2 ali 15 1 ............................................................................................................................................................................................................................LGVAELLFLL-------------------GIHRTHNQLVCTAVAILLHYFFLSTFAWLFVQGLHLYRMQVEPRNVDRGAMRFYHALGWGVPAVLLGLAVGLDPEYGNPDFCWISVHEPLIWSFAGPVVLVIVMNGTMFLLAARTSCSTGQRE---AKKTSALTLRSSFLLLLLVSASWLFGLLAVNHSI-----LAFHYLHAGLCGLQGLAVLLLFCVLNADARAAWMPACLGRKAAPEEARPAPGLGPGAYNNTALFEESGLIRITLGASTVSSVSSARSGRTQDQDSQRGRSYLRDNVLVRHGSAADHTDHSLQAHAGPTDLD........ 299\n30 -51.200 sp|Q8IZF7|GP111_HUMAN Probable G-protein coupled receptor 111 OS=Homo sapiens GN=GPR111 PE=2 SV=1 ali 17 1 ......................................................................................................................................................................................YVGLGISICSLILCLSIEVLVTEITYLRHVCIVNIAATLLMADVWFIVASFL----------------SGPITHHKGCVAATFFVHFFYLSVFFWMLAKALLILYGIMIVFLPKSVLVASLFSVGYGCPLAIAAITVAATEYLRPEICWLNWDMTKALLAFVIPALAIVVVNLITVTLVIVKTQRAIGNSMFQEVRAIVRISKNIAILTPLLGLTWGFGVATVIDDRS----LAFHIIFSLLNAFQVSPDASDQVQSERIHEDVL.......................................................................................................... 258\n31 -49.600 sp|Q8IZF6|GP112_HUMAN(removed signalp:1-27) Probable G-protein coupled receptor 112 OS=Homo sapiens GN=GPR112 PE=2 SV=2 ali 17 1 ..................................................................................................................................................................MDLSRSTVDSVNEQILALITYTGCGISSIFLGVAVVTYIAFHKLRKDPAKILINLCTALLMLNLVFLI-----------------NSWLSSFQKVGVCITAAVALHYFLLVSFTWMGLEAVHMYLALVKVFNIYPNYILKFCLVGWGIPAIMVAITVSVKKDLYGTLFCWIKDDSIFYISVVAYFCLIFLMNLSMFCTVLVQLNSVKSQIQKTRRKMILHDLKGTMSLTFLLGLTWGFAFFA------GPMRNFFLYLFAIFNTLQGFFIFVFHCVMKESVREQWQIHLCCGWLRLDNSSDGSSRCQIKVGYKQE............................................................................ 300\n32 -48.300 sp|Q9UHX3|EMR2_HUMAN(removed signalp:1-23) EGF-like module-containing mucin-like hormone receptor-like 2 OS=Homo sapiens GN=EMR2 PE=1 SV=2 ali 16 1 .....................................................................................................................................................................................................................................................................................LFL--TARNLTVVNYSSINRFMKKLMFPVGYGVPAVTVAISAASRPHLYPSRCW-LQPEKGFIWGFLGPVCAIFSVNLVLFLVTLWILKNRLSSLNSSTLRNTRMLAFKATAQLFILGCTWCLGILQVGPAA-----RVMAYLFTIINSLQGVFIFLVYCLLSQQVREQYGKWSKGIRKLKTESEMHTLSSSAKADTSKPSTVN........................................................................ 200\n33 -47.200 sp|Q8IZF5|GP113_HUMAN(removed signalp:1-25) Probable G-protein coupled receptor 113 OS=Homo sapiens GN=GPR113 PE=2 SV=1 ali 17 2 ....................................................................................................................................................................................................................................................................................................................................................YTFVGPVLAIIGVNGLVLAAMLKLLRPSLSEGPPEKRQALLGVIKALLILTPIFGLTWGLGLATLLEEVS----TVPHYIFTILNTLQGVFILLFGCLMDRKIQEALRKRFCRAQAPSSTISLVSCCLQILSCASKSMSEGIPWPSSEDMGTARS.......................................................... 154\n34 -47.200 sp|Q9NYQ6|CELR1_HUMAN(removed signalp:1-20) Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 ali 18 3 ................................................................................................TGGWSARGCELLSRNRTHVACQCSHTASFAV-------------------------------------MDISRRENGEVLPLKIVTYAAVSLSLAALLVAFVLLSLVRMLRSNLHSIHKHLAVALFLSQLVFVIGINQT-------------------ENPFLCTVVAILLHYIYMSTFAWTLVESLHVYRMLTEVRNIDTGPMRFYYVVGWGIPAIVTGLAVGLDPQYGNPDFCWLSLQDTLIWSFAGPIGAVIIINTVTSVLSAKVSCQR--KHHYYGKKGIVSLLRTAFLLLLLISATWLLGLLAVNRDA-----LSFHYLFAIFSGLQGPFVLLFHCVLNQEVRKHLKGVLGGRK.................................................................................................. 300\n35 -47.100 sp|Q9BY15|EMR3_HUMAN(removed signalp:1-21) EGF-like module-containing mucin-like hormone receptor-like 3 OS=Homo sapiens GN=EMR3 PE=1 SV=2 ali 14 1 ...................................................................................................................................................................................................................................................................................................................YGVPAVTVAISAASWPHYGTADRCWLHLDQGFMWSFLGPVCAIFSANLVLFILVFWILKRKLSSLNSSTIQNTRMLAFKATAQLFILGCTWCLGLLQVGPAA-----QVMAYLFTIINSLQGFFIFLVYCLLSQQVQKQYQKWFREIVKSKSESETYTLSSKMGPDSKPSEGDVFPGQVKRK................................................................ 180\n36 -47.000 sp|Q7Z7M1|GP144_HUMAN Probable G-protein coupled receptor 144 OS=Homo sapiens GN=GPR144 PE=2 SV=1 ali 17 1 .................................................................................................................................................................................................................................................................................................VAVSMHPGPGMRLYHATGWGVPVGIVAVTLAMLPYVAPGHCW-LNVHTNAIWAFVGPVLFVLTANTCILARVVMITVSSARRRQQQIWTQIWATVKPVLVLLPVLGLTWLAGILVHLS-------PAWAYAAVGLNSIQGLYIFLVYAACNEEVRSALQRMAEKKVAEVLRALGVWGGAAKEHSLPFSVLPLFLPPKPSTPRHPLKAPA....................................................... 213\n37 -46.800 sp|Q9BY15|EMR3_HUMAN(removed signalp:1-21) EGF-like module-containing mucin-like hormone receptor-like 3 OS=Homo sapiens GN=EMR3 PE=1 SV=2 ali 19 1 ..............................................................................................................................................FLIHVNKSHTMCNCSHLSSFAVL-MALTSQEEDPVLTVITYVGLSVSLLCLLLAALTFLLCKAIRNTSTSLHLQLSLCLFLAHLLFLV-------------------GIDRTEPKVLCSIIAGALHYLYLAAFTWMLLEGVHLFLTARNLTVVNRLMKWIMFPVGYGVPAVTVAISAASWPHLYGTDRCWLHLDQGFMWSFLGPVCAIFSANLVLFILVFWILKRKLSSSEVSTIQNTRMLAFKATAQLFILGCTWCLGLLQVGPAA-----QVMAYLFTIINSLQGFFIFLVYCLLSQQVQKQYQKWFREIVKSKS.............................................................................................. 300\n38 -46.200 sp|O60241|BAI2_HUMAN(removed signalp:1-32) Brain-specific angiogenesis inhibitor 2 OS=Homo sapiens GN=BAI2 PE=2 SV=2 ali 15 1 ..................................................................................................................................................................................SVPLVIGCAVSCMALLTLLAIYAAFWRIKSERSIILLNFCLSILASNILILV-------------------GQSRVLSKGVCTMTAAFLHFFFLSSFCWVLTEAWQSYLAVIGRMRTRLVRKRFLCLGWGLPALVVAVSVGFTRTKGYGTSCW-LSLEGGLLYAFVGPAAVIVLVNMLIGIIVFNKLMAR-PLLSSASARNAMASLWSSCVVLPLLALTWMSAVLAMTDRRS----VLFQALFAVFNSAQGFVITAVHCFLRREVQDVVKCQMGVCRADESEDSPDS........................................................................................ 299\n39 -45.400 sp|Q86SQ3|EMR4_HUMAN(removed signalp:1-15) Putative EGF-like module-containing mucin-like hormone receptor-like 4 OS=Homo sapiens GN=EMR4P PE=5 SV=1 ali follow.. 17 132 ....................................................................................................................................SEGGWSTEGCSHVHSNGSYTKCKCFHLSSFAVLVALAPKED--PVLTVITQVGLTISLLCLFLAILTFLLCRPIQNTSTSLHLELSLCLFLAHLLFLTGINRT-------------------EPEVLCSIIAGLLHFLYLACFTWMLLEGLHLFLTVRNLKVANRFKKRFMYPVGYGIPAVIIAVSAIVGPQNYGTFTCWLKLDKGFIWSFMGPVAVIILINLVFYFQVLWILRSKLSNKEVSTIQDTRVMTFKAISQLFILGCSWGLGFFMVEEVGKT-IGSIIAYSFTIINTLQGVLLFVVHCLLNRQVRLIILSVISLVPKSN............................................................................................... 442\n40 -45.300 sp|Q7Z7M1|GP144_HUMAN Probable G-protein coupled receptor 144 OS=Homo sapiens GN=GPR144 PE=2 SV=1 ali 18 2 .........................................................................................................PPHPPSPY--------------TGGAWATTGCSVAAL--YLDSTACFCNHSTSFAILLQIYEVQRGPEEESLLRTLSFVGCGVSFCALTTTFLLFLVAGVPKSERTTVHKNLTFSLASAEGFLMT-------------------SEWAKANEVACVAVTVAMHFLFLVAFSWMLVEGLLLWRKVVAVSMHPGPGMRLYHATGWGVPVGIVAVTLAMLPHDYVAP-CWLNVHTNAIWAFVGPVLFVLTANTCILARVVMITVSSARCLQQQIWTQIWATVKPVLVLLPVLGLTWLAGILVHLS-------PAWAYAAVGLNSIQGLYIFLV...................................................................................................................... 300\n41 -44.900 sp|Q8IZP9|GPR64_HUMAN G-protein coupled receptor 64 OS=Homo sapiens GN=GPR64 PE=1 SV=2 ali 19 2 .......................................................................................................................................................TCSHLTSFGVLLDLSRTSVLPAQMMALTFITYIGCGLSSIFLSVTLVTYIAFEKIRRDPSKILIQLCAALLLLNLVFLL-----------------DSWIALYKMQGLCISVAVFLHYFLLVSFTWMGLEAFHMYLALVKVFNTYRKYILKFCIVGWGVPAVVVTIILTISPDNYGLDFCWINNNAVFYITVVGYFCVIFLLNVSMFIVVLVQLCRKKKKQLGAQRKTSIQDLRSIAGLTFLLGITWGFAFFA------GPVNVTFMYLFAIFNTLQGFFIFIFYCVAKENVRKQWRRYLCCGKLR................................................................................................ 300\n42 -44.100 sp|O60242|BAI3_HUMAN(removed signalp:1-25) Brain-specific angiogenesis inhibitor 3 OS=Homo sapiens GN=BAI3 PE=1 SV=2 ali 13 10 .............................................................................................................................................................................................................................................................THNKSICTTTTAFLHFFFLASFCWVLTEAWQSYMAVTGKIRTRLIRKRFLCLGWGLPALVVATSVGFTRTKYGTDHYCWLSLEGGLLYAFVGPAAAVVLVNMVIGILVFNKLVSRDGILSATTASNAMASLWSSCVVLPLLALTWMSAVLAMTDKRS----ILFQILFAVFDSLQGFVIVMVHCILRREVQDAFRCRLRNCQDPINADSSSSFPNGHAQIMTDFEKDVDIACRSVLHKDIGPCRAATITGTLSRISLND......................................... 298\n43 -43.500 sp|Q86SQ6|GP123_HUMAN Probable G-protein coupled receptor 123 OS=Homo sapiens GN=GPR123 PE=2 SV=3 ali follow.. 9 15 ...............................................................................................................................................................................EFLHPVVYACTAVMLLCLLASFVTYIVHQSAI-KGRHTLLNFCFHAALTFTVFAGGINRT-------------------KYPILCQAVGIVLHYSTLSTMLWIGVTARNIYKQVTKKAPLCRQPLLRFYLVSGGVPFIICGVTAATNIRNYGTE-YCWMAWEPSLGAFYGPAAIITLVTCVYFLGTYVQLRRHPGRSVLQNEHSFQAQLRAAAFTLFLFTATWAFGALAVSQGH--FLDMVFSCLYGAFCVTLGLFVLIHHCAKREDVWQCWWACCPPRKDAHPALDANGAALGRAACLHSPGLGQPRGFAHPPGPCKMTNLQAAQGHASCLSPATPCCAKMHCEPLTADEAHVHLQEEGAFGHDPHLHGCLQGRTK. 422\n44 -43.100 sp|Q86SQ4|GP126_HUMAN(removed signalp:1-37) G-protein coupled receptor 126 OS=Homo sapiens GN=GPR126 PE=1 SV=3 ali 12 1 ...........................................................................................................................................................................................................................................................................HFFLLATFTWMGLEAIHMYIALVKVFNTYRRYILKFCIIGWGLPALVVSVVLASRNNNEGDEFCWIQDPVIFYVTCAGYFGVMFFLNIAMFIVVMVQICGRNGKRNRTLREEVLRNLRSVVSLTFLLGMTWGFAFFAWGPLN-----IPFMYLFSIFNSLQGLFIFIFHCAMKENVQKQWRQHLCCGRFRLADNSDWSKTATNIIKKSSDNLGKSLSSSSIGSNSTYLTSKSKSSSTTYFKRNSHTDNVSYEHSFNKSGSLRQCFHGQVLVKTG............ 282\n45 -43.100 sp|Q96K78|GP128_HUMAN(removed signalp:1-26) Probable G-protein coupled receptor 128 OS=Homo sapiens GN=GPR128 PE=1 SV=2 ali 13 1 ...............................................................................................................................................................................................SMLIFNLLFVFGIENSNKNLQTSDGDINNIDFDNNDIPRTDTI-------------------NIPNPMCTAIAALLHYFLLVTFTWNALSAAQLYYLLIRTMKPPRHFILFISLIGWGVPAIVVAITVGVIYSQNGNN-PNGVIKSPLLWSFIVPVTIILISNVVMFITISIKVLWKNNQNTSTKKVSSMKKIVSTLSVAVVFGITWILAYLM---VNDDSIRIVFSYIFCLFNTTQGLQIFILYTVRTKVFQSEASKVLMLLSSIGRRKSLPSVTRPRLRVKMYNFLRSLPTLHER................................................................. 296\n46 -42.400 sp|Q9UHX3|EMR2_HUMAN(removed signalp:1-23) EGF-like module-containing mucin-like hormone receptor-like 2 OS=Homo sapiens GN=EMR2 PE=1 SV=2 ali 21 5 ....................................................................................................QKVLCWEHGQNGC----------------------HWATTGCSTIGTRDTSTICRCTHLSSFAVLMAHYDVQEEDPVLTVITYMGLSVSLLCLLLAALTFLLCKAIQNTSTSLHLQLSLCLFLAHLLFLVAIDQT-------------------GHKVLCSIIAGTLHYLYLATLTWMLLEALYLFLTARNLTVVNRFMKKLMFPVGYGVPAVTVAISAASRPHLYGTSRCWLQPEKGFIWGFLGPVCAIFSVNLVLFLVTLWILKNRLSSSEVSTLRNTRMLAFKATAQLFILGCTWCLGILQ------GPAARVMAYLFTIINSLQGVF.......................................................................................................................... 300\n47 -41.900 sp|Q8IZF6|GP112_HUMAN(removed signalp:1-27) Probable G-protein coupled receptor 112 OS=Homo sapiens GN=GPR112 PE=2 SV=2 ali 15 5 .....................................................................................................................................................................................................................................................................................................................................TTPFCW-IKDDSIFYISVVAYFCLIFLMNLSMFCTVLVQLNSVKSQIQKTRRKMILHDLKGTMSLTFLLGLTWGFAFFAWGPMR-----NFFLYLFAIFNTLQGFFIFVFHCVMKESVREQWQIHLCCGWLRLDNSSDGSSRCQIKVGYKQEGLKKIFEHKLLTPSLKSTATSSTFKSLGSAQGTPSEISFPNDDFDKDPYCSS........................ 202\n48 -41.700 sp|Q86Y34|GPR97_HUMAN(removed signalp:1-20) Probable G-protein coupled receptor 97 OS=Homo sapiens GN=GPR97 PE=1 SV=1 ali follow.. 17 194 .......................................................................................................TCWDVTKGTT----------------GDWSSEGCSTE------VRPEGTVCCCDHLTFFALLLRPTLDQSTVHILTRISQAGCGVSMIFLAFTIILYAFLRFKSEDAPKIHVALGGSLFLLNLAFLV-----------------NVGSGSKGSDAACWARGAVFHYFLLCAFTWMGLEAFHLYLLAVRVFNTYGHYFLKLSLVGWGLPALMVIGTGSANSYGLLELCWFREGTTMYALYITGYFLITFLFGMVVLALVVWKIFTLSRATAVKERGKNRKKVLTLLGLSSLVGVTWGLAIFTP-------LGLSTVYIFALFNSLQGVFICCWFTILYLPSQSTTVSSSTARLDQAHSASQE......................................................................................... 529\n49 -41.200 sp|Q8IZF4|GP114_HUMAN(removed signalp:1-21) Probable G-protein coupled receptor 114 OS=Homo sapiens GN=GPR114 PE=2 SV=3 ali follow.. 19 167 .......................................................................................................TCWKEGARKQ--------------PWGGWSPEGCRTEQP--SHSQVLCRCNHLTYFAVLMQLSPALVPAELLAPLTYISLVGCSISIVASLITVLLHFHFRKQSDSLTRIHMNLHASVLLLNIAFLL----------------SPAFAMSPVPGSACTALAAALHYALLSCLTWMAIEGFNLYLLLGRVYNIYRRYVFKLGVLGWGAPALLVLLSLSVKSSVYNMSICWVRSPVVHSVLVMGYGGLTSLFNLVVLAWALWTL-RRLRERADAPSVRACHDTVTVLGLTVLLGTTWALAFFS------GVFLLPQLFLFTILNSLYGFFLFLWFCSQRCRSEAEAKAQIEAFSSSQTTQ............................................................................................ 507\n50 -40.600 sp|Q9Y653|GPR56_HUMAN(removed signalp:1-25) G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 ali 16 1 ....................................................................................................................................................................................................................................................................RASAIFLHFSLLTCLSWMGLEGYNLYRLVVEVFGTYPGYLLKLSAMGWGFPIFLVTLVALVDVDNYGPSMCWIRDSLVSYITNLGLFSLVFLFNMAMLATMVV------QILRLRPHTQKWSHVLTLLGLSLVLGLPWALIFF---SFASGTFQLVVLYLFSIITSFQGFLIFIWYWSMRLQARGGPSPLKSNSDSARLPISSGSTSSSRI.................................................................................. 218\n51 -40.300 sp|Q8IWK6|GP125_HUMAN(removed signalp:1-36) Probable G-protein coupled receptor 125 OS=Homo sapiens GN=GPR125 PE=1 SV=2 ali 12 1 ..........................................................................................................................................................................................................LIRISLKSWHMLVNLCFHIFLTCVVFVGGITQT-------------------RNASICQAVGIILHYSTLATVLWVGVTARNIYKQVTKKAKRCPRPMLRFYLIGGGIPIIVCGITAAANIKNYGSRPYCWMAWEPSLGAFYGPASFITFVNCMYFLSIFIQLLSLISTSALENEHTFHSQLLGASLTLLLYVALWMFGALAVSL--YYPLDLVFSFVFGATSLSFSAFFVVHHCVNREDVRLAWIMTCCPGRSSYSVQVNVQPPNSNGTNGEA............................................................................. 300\n52 -40.200 sp|O95490|LPHN2_HUMAN(removed signalp:1-25) Latrophilin-2 OS=Homo sapiens GN=LPHN2 PE=1 SV=2 ali 16 5 .......................................................................................PDNYFNANCMGYWSTQGCKLVDTNKTRTTCACSHLTNF---------------------------------AILMAHREIAYKDGVHELLLTVITWVGIVISLVCLAICIFTFCFFRGLQSDRNTIHKNLCINLFIAEFIFLIGIDKT-------------------KYAIACPIFAGLLHFFFLAAFAWMCLEGVQLYLMLVEVFESEYSRKKYYYVAGYLFPATVVGVSAAIDYKSYGTKACWLHVDNYFIWSFIGPVTFIILLNIIFLVITLCKMVKHSNKPDSSRLENIKSWVLGAFALLCLLGLTWSFGLLF------NEETIVMAYLFTIFNAF.............................................................................................................................. 300\n53 -39.600 sp|Q96K78|GP128_HUMAN(removed signalp:1-26) Probable G-protein coupled receptor 128 OS=Homo sapiens GN=GPR128 PE=1 SV=2 ali 11 2 ......................................................................................................................................................................................................................................................................................................................................................FIVPVTIILISNVVMFITISIKVLWKNNQNTSTKKVSSMKKIVSTLSVAVVFGITWILAYLML--VNDDSIRIVFSYIFCLFNTTQGLQIFILYTVRTKVFQSEASKVLMLLSSIGRRKSLPSVTRPRLRVKMYNFLRSLPTLHERFRLLETSPSTEEITLSESDNAKESI........................................ 171\n54 -39.600 sp|Q9NYQ6|CELR1_HUMAN(removed signalp:1-20) Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 ali 13 1 ...........................................................................................................................................................................................................................................................................................................MRFYYVVGWGIPAIVTGLAVGLDPQGYGNPCW-LSLQDTLIWSFAGPIGAVIIINTVTSVLSAKVSCQRKH--HYYGKKGIVSLLRTAFLLLLLISATWLLGLLAVNRDA-----LSFHYLFAIFSGLQGPFVLLFHCVLNQEVRKHLKGVLGGRKLHLEDSATTRATLLTRSLNCNTTFGDGPDMLRTDLGESTASLDSIVRDEGIQKLGVSSGLVRGSHGEPDASLMPRSCKDPPGHDSDSDSELSLDEQS. 247\n55 -38.800 sp|P48960|CD97_HUMAN(removed signalp:1-20) CD97 antigen OS=Homo sapiens GN=CD97 PE=1 SV=4 ali 21 24 .......................................................................................................LCWKSDSDRG----------------GHWATEGCQVLGS--KNGSTTCQCSHLSSFAILMAHYDVEDW-----KLTLITRVGLALSLFCLLLCILTFLLVRPIQGSRTTIHLHLCICLFVGSTIFLA-----------------GIENEGGQVGLRCRLVAGLLHYCFLAAFCWMSLEGLELYFLVVRVFQGQGLSTRWLCLIGYGVPLLIVGVSAAIYSKGYGRRYCWLDFEQGFLWSFLGPVTFIILCNAVIFVTTVWKLTQKFSEPDMKKLKKARALTITAIAQLFLLGCTWVFGLFI------DDRSLVLTYV..................................................................................................................................... 300\n56 -38.500 sp|Q6QNK2|GP133_HUMAN(removed signalp:1-25) Probable G-protein coupled receptor 133 OS=Homo sapiens GN=GPR133 PE=2 SV=1 ali 20 34 .......................................................................................................YCLDFSS-----------------GEGVWSNHGCALTRG--NLTYSVCRCTHLTNFAILMQVVPLELARGHQVALSSISYVGCSLSVLCLVATLVTFAVLSSVSNQRYHIHANLSFAVLVAQVLLLISFRLE-------------------PGTTPCQVMAVLLHYFFLSAFAWMLVEGLHLYSMVIKVFGSEDSKHRYYYGMGWGFPLLICIISLSFAMDSYGTNNCWLSLASGAIWAFVAPALFVIVVNIGILIAVTRVIISADNYKIHGDPSAFKLTAKAVAVLLPILGTSWVF......................................................................................................................................................... 300\n57 -38.300 sp|Q9HAR2|LPHN3_HUMAN(removed signalp:1-21) Latrophilin-3 OS=Homo sapiens GN=LPHN3 PE=1 SV=2 ali 19 33 .......................................................................................................NCWSYSKRT---------------MTGYWSTQGCRLLTT--NKTHTTCSCNHLTNFAVLMAVEVKHSDAVHDLLLDVITWVGILLSLVCLLICIFTFCFFRGLQSDRNTIHKNLCISLFVAELLFLIGINRT-------------------DQPIACAVFAALLHFFFLAAFTWMFLEGVQLYIMLVEVFESEHSRRKYFYLVGYGMPALIVAVSAAVDYRSYGTD-CWLRLDTYFIWSFIGPATLIIMLNVIFLGIALYKMFHHTAKPESGCLDNIKSWVIGAIALLCLLGLTWAF......................................................................................................................................................... 299\n58 -38.300 sp|Q96PE1|GP124_HUMAN(removed signalp:1-33) Probable G-protein coupled receptor 124 OS=Homo sapiens GN=GPR124 PE=1 SV=2 ali 12 1 .............................................................................................................................................................................................LFATIITYILNHSSIRVSRKGWHMLLNLCFHIAMTSAVFAGGITLT-------------------NYQMVCQAVGITLHYSSLSTLLWMGVKARVLHKELTWRAPPPPSPMLRFYLIAGGIPLIICGITAAVNIHYRDHSPYCWLVWRPSLGAFYIPVALILLITWIYFLCAGLRLRGPLAPEDGDSLYSPGVQLGALVTTHFLYLAMWACGALAVSQ--RWLPRVVCSCLYGVAASALGLFVFTHHCARRRDVRASWRA........................................................................................................ 299\n59 -38.200 sp|O14514|BAI1_HUMAN(removed signalp:1-30) Brain-specific angiogenesis inhibitor 1 OS=Homo sapiens GN=BAI1 PE=1 SV=1 ali 12 1 .......................................................................................................................................................................................................................................................................................................................................NYCW-LSLEGGLLYAFVGPAAAVVLVNMVIGILVFNKLVSKDGITDKKLKERAGASLWSSCVVLPLLALTWMSAVLAVTDRRS----ALFQILFAVFDSLEGFVIVMVHCILRREVQDAVKCRVVDRQEEGNGDSGGSFQNGHAQLMTDFEKDVDLACRSVLNKDIAACRTATITGTLKRPSLPEEEKLKLAHAKGPPTNFNSLPANVSKLHLHGSPRYPGGPLP. 220\n60 -38.100 sp|Q9HCU4|CELR2_HUMAN(removed signalp:1-31) Cadherin EGF LAG seven-pass G-type receptor 2 OS=Homo sapiens GN=CELSR2 PE=1 SV=1 ali 18 37 .......................................................................................................ICWNHSILVS--------------GTGGWSARGCEVVFRNESHVSCQCNHMTSFAVL----MDVSRRENGEILPLKTLTYVALGVTLAALLLTFFFLTLLRILRSNQHGIRRNLTAALGLAQLVFLL-------------------GINQADLPFACTVIAILLHFLYLCTFSWALLEALHLYRALTEVRDVNTGPMRFYYMLGWGVPAFITGLAVGLDPEYGNPDFCWLSIYDTLIWSFAGPVAFAVSMSVFLYILAARASCAA--QRQGFEKKGPVSGLQPSFAVLLLLSATWLLALL...................................................................................................................................................... 300\n61 -38.000 sp|Q8WXG9|GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=1 ali 11 3 ....................................................................................................QTSLCWNQAA-----------------ASWLSDSQFCKVIEE--TADYVECACSHMSVYAVYARTDNLSSY-----NEAFFTSGFICISGLCLAVLSHIFCARYSMF--AAKLLTHMMAASLGTQILFLA-----------------SAYASPQLAEESCSAMAAVTHYLYLCQFSWMLIQSVNFWYVLVMNDEHTERRYLLFFLLSWGLPAFVVILLIVILKGIYHGDLCFIPNVYAALFTAALVPLTCLVVVFVVFIHAYQVKPQWKAYDDVFRGRTNAAEIPLILYLFALISVTWLWGGLH------AYRHFWMLVLFVIFNSLQGLYV......................................................................................................................... 299\n62 -37.400 sp|Q8IZF3|GP115_HUMAN(removed signalp:1-21) Probable G-protein coupled receptor 115 OS=Homo sapiens GN=GPR115 PE=2 SV=3 ali 15 20 .......................................................................................KTRNARAQCKRRWDEKACQMMLDIRNEVKCRCNYTSVVMS-------------------------------------SILMSSKSMTDKVLDYITCIGLSVSILSLVLCLIIEATVTEISYMRHVCIVNIAVSLLTANVWFII----------------GSHFNIKAQDYNMCVAVTFFSHFFYLSLFFWMLFKALLIIYGILVIFMMKSRMMVIGFAIGYGCPLIIAVTTVAITEYMRPEACWLNWDNTKALLAFAIPAFVIVAVNLIVVLVVAVNTQRSIGSSKSQDVVIIMRISKNVAILTPLLGLTWGF......................................................................................................................................................... 299\n63 -36.000 sp|Q5UAW9|GP157_HUMAN Probable G-protein coupled receptor 157 OS=Homo sapiens GN=GPR157 PE=1 SV=2 ali follow.. 13 1 ....................................................................................................................................................................MQPSPPPTELVPSERAVVLLSCALSALGSGLLVATHALWPDLRSRARRLLLFLSLADLLSAASYFY-----------------GVLQNFAGPSWDCVLQGALSTFANTSSFFWTVAIALYLYLSIVRAARGPDRLLWAFHVVSWGVPLVITVAAVALKKIGYDASCWIDLEAKDHVLWMKLWEMLAYVLLPLLYLLVRKHINRAHTASQEHRLLRHSSMADKKLVLIPLI-VWSTVRFVLTLCGSPAVQTPVLVVLHGIGNTFQGGANCIMFVLCTRAVRTRLFSLCCCCCSSQPPTKSPAGTPKAPAPSKPGESQESQGTPGELPST............................................................. 335\n64 -35.900 sp|Q9NYQ7|CELR3_HUMAN(removed signalp:1-31) Cadherin EGF LAG seven-pass G-type receptor 3 OS=Homo sapiens GN=CELSR3 PE=1 SV=2 ali 20 48 .......................................................................................................ICWDPPGLAE--------------QHGVWTARDCELVHR--NGSHARCRCSRTGTFGVLMDASPRERLEGDLELLAVFTHVVVAVSVAALVLTAAILLSLRSLKSNVRGIHANVAAALGVAELLFLLGIHRT-------------------HNQLVCTAVAILLHYFFLSTFAWLFVQGLHLYRMQVEPRNVDRGAMRFYHALGWGVPAVLLGLAVGLDPEYGNPDFCWISVHEPLIWSFAGPVVLVIVMNGTMFLLAARTS---CSTGQREAKKTSALTLRSSFLLL.................................................................................................................................................................. 300\n65 -35.900 sp|Q86SQ4|GP126_HUMAN(removed signalp:1-37) G-protein coupled receptor 126 OS=Homo sapiens GN=GPR126 PE=1 SV=3 ali 17 15 .......................................................................................................ICWDLNKNK---------------SFGGWNTSGCAHRDSDASETVCLCNHFTHFGVLMDLPRSASQLDARNTKVLTFISYIGCGISAIFSAATLLTYVAFEKLRRYPSKILMNLSTALLFLNLLFLL-----------------DGWITSFNVDGLCIAVAVLLHFFLLATFTWMGLEAIHMYIALVKVFNTYRRYILKFCIIGWGLPALVVSVVLASRNNNEGDEFCWIQDPVIFYVTCAGYFGVMFFLNIAMFIVVMVQICGNGKRSNRTLREEVLRNLRSVVSLTFLLGMTWGFAFFA..................................................................................................................................................... 300\n66 -35.500 sp|Q8IZP9|GPR64_HUMAN G-protein coupled receptor 64 OS=Homo sapiens GN=GPR64 PE=1 SV=2 ali 13 1 ...............................................................................................................................................................................................................................................................................................TIILTISPD---------------NYGLGSYGKFPNGSPDDFCW-INNNAVFYITVVGYFCVIFLLNVSMFIVVLVQLCRKKKKQLGAQRKTSIQDLRSIAGLTFLLGITWGFAFFAW-----GPVNVTFMYLFAIFNTLQGFFIFIFYCVAKENVRKQWRRYLCCGKLRLAENSDWSKTATNGLKKQTVNQGVSSSSNSLQSSSNSTNSTTLLVNNDCSVHASGNGNASTERNGVSFSVQNGDVCLHDFTGKQHMFNEKEDSCN. 245\n67 -35.300 sp|O94910|LPHN1_HUMAN Latrophilin-1 OS=Homo sapiens GN=LPHN1 PE=1 SV=1 ali 22 51 .......................................................................................................NCWNYSERS---------------MLGYWSTQGCRLVES--NKTHTTCACSHLTNFAVLMAHREIYQGRINELLLSVITWVGIVISLVCLAICISTFCFLRGLQTDRNTIHKNLCINLFLAELLFLVGIDKT-------------------QYEIACPIFAGLLHYFFLAAFSWLCLEGVHLYLLLVEVFESEYSRTKYYYLGGYCFPALVVGIAAAIDYRSYGTKACWLRVDNYFIWSFIGPVSFVIVVNLVFLMVTLHKMIRSSSVLKPDSSR............................................................................................................................................................................... 292\n68 -35.000 sp|Q9HBW9|ELTD1_HUMAN(removed signalp:1-19) EGF, latrophilin and seven transmembrane domain-containing protein 1 OS=Homo sapiens GN=ELTD1 PE=1 SV=3 ali 20 50 .......................................................................................................LCWNYSPDT---------------MNGSWSSEGCELTYS---NETHTSCRCNHLTHFAILMSSGPSIGIKDYNILTRITQLGIIISLICLAICIFTFWFFSEIQSTRTTIHKNLCCSLFLAELVFLVGINTN-------------------TNKLFCSIIAGLLHYFFLAAFAWMCIEGIHLYLIVVGVIYNKGFLHKNFYIFGYLSPAVVVGFSAALGYRYYGTTCW-LSTENNFIWSFIGPACLIILVNLLAFGVIIYKVFRHTAGPEVSCFENIRSCARG....................................................................................................................................................................... 300\n69 -34.600 sp|Q9Y653|GPR56_HUMAN(removed signalp:1-25) G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 ali 15 20 .......................................................................................................QCWVEDPTLS--------------SPGHWSSAGCETVRR----ETQTSCFCNHLTYFAVLMVSSVEVDAVHKHYLSLLSYVGCVVSALACLVTIAAYLCSRKPRDYTIKVHMNLLLAVFLLDTSFLL-----------------SEPVALTGSEAGCRASAIFLHFSLLTCLSWMGLEGYNLYRLVVEVFGTYPGYLLKLSAMGWGFPIFLVTLVALVDVDNYYPSMCWIRDSLVSYITNLGLFSLVFLFNMAMLATMVVQILR------LRPHTQKWSHVLTLLGLSLVLGLPWAL......................................................................................................................................................... 300\n70 -33.800 sp|O60242|BAI3_HUMAN(removed signalp:1-25) Brain-specific angiogenesis inhibitor 3 OS=Homo sapiens GN=BAI3 PE=1 SV=2 ali 16 10 .............................................................SKIIVVTIRPEPKTTDSFLEIELAHLANGTLNPYC-------VLWDDSKTNE--------------SLGTWSTQGCKTVLT---DASHTKCLCDRLSTFAILAQQPREIIMESSGTPSVTLIVGSGLSCLALITLAVVYAALWRIRSERSIILINFCLSIISSNILILV-------------------GQTQTHNKSICTTTTAFLHFFFLASFCWVLTEAWQSYMAVTGKIRTRLIRKR-FLCLGWGLPALVVATSVGFTRTYGTDHYCWLSLEGGLLYAFVGPAAAVVLVNMVIGILVFNKLVSRDGILDKKLKHRAGQMSEPHSGLT.................................................................................................................................................................. 298\n71 -33.100 sp|Q8IZF2|GP116_HUMAN(removed signalp:1-22) Probable G-protein coupled receptor 116 OS=Homo sapiens GN=GPR116 PE=1 SV=3 ali 18 20 ...................................................................................FKNNSPSGGETKC-------VFWNFRLAN---------------NTGGWDSSGCYVEEG--DGDNVTCICDHLTSFSILMSPDSPDPSSLLGILLDIISYVGVGFSILSLAACLVVEAVVWKSSYMRHTCIVNIAASLLVANTWFIV--------------VAAIQDNRYILCKTACVAATFFIHFFYLSVFFWMLTLGLMLFYRLVFILTSRSTQKAIAFCLGYGCPLAISVITLGATQYTRKNVCWLNWEDTKALLAFAIPALIIVVVNITITIVVITKILSIGDKPCKQEKSSLFQISKSI...................................................................................................................................................................... 299\n72 -31.700 sp|P51810|GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 ali follow.. 11 8 ............................................................................................................................................................TFCCPTRDAATQLVLSFQPRAFHALCLGSGGLRLALGLLQLLPGRRPATSPPASVRILRAAAACDLLGCLGMVIRSTVWLGFPNFVDSVSDMNHTEIWPAAF-CVGSAMWIQLLYSACFWWLFCYAVDAYLVIRRS--AGLSTILLYHIMAWGLATLLCVEGAAMLYYPSVSRCERGLDHAIPHYVMYLPLLLVLVANPILFQKTVTAVASLLKGRTENERRMGAVIKIRFFKIMLVLIICWLSNIIN-SLKPVRTAAKTTWFIMGILNPAQGFLLSLAFYGWTGCSLGFQSPRKEIQWESLTTSAAEGAHPSPLMPHENPASGKVSQVGGQTSDEALSMLSEGSDASTIEIHTASESCNKNEGDPALPTHGDL....................... 404\n73 -31.100 sp|Q5T601|GP110_HUMAN(removed signalp:1-19) Probable G-protein coupled receptor 110 OS=Homo sapiens GN=GPR110 PE=2 SV=2 ali 17 53 ...................................................................................FSKIESNLSQPHC-VFWD----W-------------------------------NDAGCHLVNETQDIVTCQCTHLTSFSILMSPFVPSTIFPVVKWITYVGLGISIGSLILCLIIEALFWKQSHTRRICMVNIALSLLIADVWFIVGATV----------------DTTVNPSGVCTAAVFFTHFFYLSLFFWMLMLGILLAYRIILVFMAQHLMMAVGFCLGYGCPLIISVITIAVNTYKRKDVCWLNWSNGKPLLAFVVPALAIVAVNFVVVLLVLTKL............................................................................................................................................................................................ 300\n74 -30.700 sp|O60242|BAI3_HUMAN(removed signalp:1-25) Brain-specific angiogenesis inhibitor 3 OS=Homo sapiens GN=BAI3 PE=1 SV=2 ali 10 2 .........................................................................................................................................................................................................................................................................................................................................................................AKCGVVSTTALSATTASNAMASLWSSCVVLPLLALTWMSAVLAMTDKRS----ILFQILFAVFDSLQGFVIVMVHCILRREVQDAFRCRLRNCQDPINADSSSSFPNGHAQIMTDFEKDVDIACRSVLHKDIGPCRAATITGTLSRISLNDDEEEKGTNPEGLSYSTLPGNVISKVIIQQPTGLHMPMSMN. 188\n75 -30.300 sp|Q8WXG9|GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=1 ali 9 1 .................................................................................................................................................................................................................................................................................................VMNDEHTERRYLLFFLLSWGLPAFVVILLIVILKGIYHGDLCFIPNVYAALFTAALVPLTCLVVVFVVFIHAYQVKPQWKAYDDVFRGRTNAAEIPLILYLFALISVTWLWGGL-----HMAYRHFWMLVLFVIFNSLQGLYVFMVYFILHNQMCCPMKASYTVEMNGHPGPSTAFFTPGSGMPPAGGEISKSTQNLIGAMEEVPPDWERASFQQGSQASPDLKPSPQNGATSSGGYGQGSLIADEESQEFDDLIFALKTGAGL 272